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ABSTRACT
A highly sensitive, specific, real time, and field-deployable surveillance tool is
critical to the control of pathogens and infections, as well as ecological impact of chemicals
exposure. This work investigates the development of a low cost biosensing platform that
can be used for viral disease diagnosis and chemical detection. The sensing mechanism is
known as AC electrokinetics (ACEK) capacitive sensing. By applying an inhomogeneous
AC electric field on sensor electrodes, positive dielectrophoresis is induced to accelerate
the travel of analytes. The same applied AC signal also directly measures the capture of
target by the probe on sensor surface. The realized sensing platform is not only rapid but
also highly sensitive and specific. Built on our initial proof-of-concept of ACEK capacitive
sensing, this work studies in details the immobilization of probes on electrode surface,
electrode design, the interactions between biomolecules such as nucleic acids and testing
buffers, and the effect of dielectrophoresis and accompanying ACEK phenomena.
Experimental comparisons are made between sensors with various probe immobilization,
different electrode designs, testing buffer and detection protocols. As a result, much higher
sensitivity and selectivity have been achieved. We are able to successfully detect virus
particles in nasal swab samples, specific antibody in serum and whole genome nuclei acids
in serum. To extend the application of this sensing method on other electrode platform,
polyimide-based laser printed electrodes are also investigated and successfully
demonstrated for small molecule detection. However, this type of sensor exhibits high
internal resistance, making it only suitable for chemical or particle detection in highly
resistive electrolyte, such as de-ionized water. With procedural and design improvements
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discussed in this work, it is expected that ACEK capacitive sensing will become a
disruptive technology in on-site biochemical detection.
Keywords: capacitive sensing, ACEK, point of care, virus, protein, nucleic acid.
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CHAPTER 1
INTRODUCTION
1.1 History, development and challenges of biosensor
The field of biosensor, in the past 60 years, has undoubtedly attracted a great
amount of research and development efforts. Researchers and scientists from chemistry,
physics, microbiology, as well as various disciplines of engineering have been deeply
involved in this interdisciplinary field. In 1956, Professor Leland C. Clark publishes his
monumental paper on the development of an oxygen probe using the enzyme glucose
oxidase (GOX) in transducer in measurement of glucose. In 1962 he described how “to
make electrochemical sensors (pH, polarographic, potentiometric or conductometric) more
intelligent” by adding “enzyme transducers as membrane enclosed sandwiches”[1].
Professor Clark is the inventor of the Clark electrode, which a device used for measuring
oxygen in blood, water and other liquids[2]. He is considered as the "father of biosensors"
and the modern-day glucose sensor used daily by millions of diabetics is based on his
research.
Biosensor today is either sophisticated, high-throughput laboratory machine
capable of rapid, accurate and convenient measurement of complex biological interactions
and components or easy-to-use, portable device for use by non-specialists for decentralised,
in situ or home analysis. The former are expensive and the latter are mass produced and
inexpensive.[3]
Expansion of human activities and process of globalization speed up the high pace
of people’s life and engagement, as well as the spread of pathogens and their vectors.
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Influenza, for instance, is a very common infectious disease. While it usually causes only
mild illness, it can be life-threatening for infants, elderly and immunodeficient people.
Worldwide, seasonal influenza is estimated to cause 250,000–500,000 deaths per year.
Historically, influenza caused pandemic such as the Spanish flu pandemic of 1918. Recent
years, worldwide human health has been challenged by pandemic threats such as the
emergence of highly pathogenic influenza A virus from mutation of avian influenza or
other animal reservoirs. It is well established that timely diagnosis of viral infection can
shorten the delay in treatment, reduce the duration of hospitalization, and improve the
quality of patient care. Recently, the potential health consequences of Zika virus infection,
and the lack of effective treatment for the disease, the World Health Organization (WHO)
declared a public health emergency and released a call for the development of new
diagnostic tests for Zika virus infection. Zika virus is a flavivirus (family Flaviviridae) that
was first identified in Nigeria in 1947.[4] Many people infected with Zika virus were either
asymptomatic[5] or reported having only mild, nonspecific influenza-like symptoms, such
as fever and headache. Most patients typically recover within several days to a week.[6]
However, the viral infection occasionally causes severe manifestations, including GuillainBarre syndrome, in adults and microcephaly in babies when the mother has been infected
with the virus during pregnancy. There also has been increasing concerns regarding the
potential risk of sexual transmission of Zika virus during pregnancy.[7] Therefore, a rapid
point of care (POC) diagnosis for infectious diseases outside hospital is desired and will
have significant impact on the healthcare.
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Despite for the area of infectious diseases detection, recent years have also seen a
growing need to monitor and rapidly detect contaminants in the environment and food
supply such as bisphenol A (BPA). BPA is a monomer widely used in a variety of consumer
products, including plastics, food packaging, dental sealants, and thermal receipts. It was
reported that 8-15 billion pounds of the material were produced annually[8]. Because of
the widespread use of BPA, the compound has been detected in aquatic environments,
which are considered the ultimate reservoirs for environmental anthropogenic chemicals.
BPA is a known endocrine disruptor with estrogenic, antiandrogen properties and can
disrupt thyroid function. Studies have demonstrated that BPA can have significant
biological effects at low, environmentally relevant doses[9],[10]. Significant levels of BPA
have been detected in river water, river sediments, and fish muscles. In particular, there is
concern that the consumption of fish could contribute to the total intake of BPA in human
populations. Detection and quantification of BPA concentrations in water are critical for
the U.S. Environmental Protection Agency to develop water quality standards and to
evaluate environmental risk levels for the protection of human health. The majority of
current BPA detection methods rely on high performance liquid chromatography (HPLC)
or enzyme-linked immunosorbent assay (ELISA), which require the use of costly
instruments by skilled personnel with complex and time-consuming operation[11].
Therefore, a simple and affordable method to monitor BPA level in environmental samples
with high sensitivity remains critical.
Similar to the need of simple and easy-to-use method to detect BPA, interest of
developing detection method of influenza is also growing. Currently, accurate diagnosis of
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influenza virus is done by either virus isolation, detection of virus-specific antibodies or
genomic detection by reverse-transcription polymerase chain reaction (RT–PCR). Virus
isolation and antibody tests take several days and can hardly meet the time-sensitive needs
of patient management. Real-time RT–PCR-based molecular assays can yield results in
hours and are being increasingly used for early diagnosis. However, real-time RT-PCR
requires good financial and technical resources to perform, often restricted to central
laboratories.

1.2 Improvement on capacitive sensing
Previously, our group has developed an AC electrokinetics-based capacitive
sensing method with microfabricated interdigitated electrodes that could reach a limit of
antigen-antibody detection of 10 ng/ml. With adoption of cross linker during electrodes
functionalization and studies on immobilization and testing buffers, the limit of detection
(LOD) are improved significantly to pg/mL level and the sensing platform is expanded to
nucleic acid and chemical detections. In addition, by researches on the various designs of
electrodes, compatibility of ACEK sensing method was studied to support rapid and low
cost prototyping and manufacturing, and AC electroosmotic effect is also utilized for
capacitive sensing, expanding the varieties of ACEK capacitive sensing.
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CHAPTER 2
LITERATURE REVIEW
The clear and enormous need for healthcare and environmental monitoring
continues to drive substantial research in the field of biosensor. The last three decades have
witnessed the remarkable development and progress of sophisticated and accurate
traditional laboratory based sensing instrumentations. Although both high throughput
sensing in traditional laboratory based sensing instrumentation and of low cost sensing for
field or personal use are highly demanded, the need for low cost sensing for healthcare and
environmental monitoring, for example, has particular benefit to developing economies, in
particular within Africa and South East Asia[12]. There are special needs for low-cost
point-of-care (POC) diagnostic and monitoring tools due to the lack of suitable testing
clinics and facility. Additionally, while considerable research effort has been devoted to
biosensors for diagnosis at the bedside or in the clinic, there have been few successful
devices being routinely used in real applications.
While considerable research effort has been devoted to biosensors for diagnosis at
the bedside or in the clinic, there are few successful POC devices being routinely used in
real applications. POC diagnostic systems require the following critical attributes:
sufficient sensitivity, robustness, simple test procedure and short sample-to-result time.
Recent progress in the development of such systems has been fueled by rapid innovations
in microfluidics, miniaturization, and enhanced signal detection technologies. Current POC
diagnostics, based primarily on immunoassay technologies, have been the mainstream
application for decades. However, traditional immunoassay technologies are not very
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sensitive and need a long time to yield result, which limits the applicability of these tests
to many clinical conditions. The obstacle to achieving rapid detection is the long diffusion
time for the target bioparticles to reach the sensing site of a sensor. So accelerating the
diffusion process has been an essential part of the study. Most of the reported biomolecular
sensors work with heavily processed samples, requiring purification, pre-concentration,
etc. in addition to sophisticated data processing and expensive equipment. Another
challenge is specificity. A number of ultrasensitive immunosensing methods have been
developed, many based on nanotechnology. However, only a few of the newer
ultrasensitive methods have been evaluated with real patient samples, which is key to
establishing clinical sensitivity and selectivity.

2.1 Electrochemical enzymatic biosensors
Electrochemical biosensors have traditionally received the major share of the
attention in biosensor development[13]. Due to the simple, inexpensive and yet accurate
and sensitive platform electrochemical biosensors have provided, they have always been a
major role in the move towards simplified testing, including home-use devices[14]–[17].
Being capable of mass production with low cost and adequate accuracy and
sensitivity are major criteria for successful commercialization of POC sensors and devices.
Categorized as amperometric sensors, the electrochemical glucose sensors have attracted
the most attention due to the sensors’ unbeaten sensitivity and selectivity, even though
numerous processes and methodologies have been developed for creating new glucose
biosensors such as electrochemical methods[18], colorimetry[19], conductometry[20],
optical methods[21], and fluorescent spectroscopy[22]. The portable glucose biosensors
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which only requires a 0.3- to 1.5-μL drop of blood and usually take less than 10 seconds
for the result have achieved the most significant commercial success[23]. Amperometric
biosensors function by the production of a current (typically in nA to μA range) when a
potential is applied between two electrodes.

2.2 Labeled affinity biosensor
Affinity biosensor measures the affinity between bioreceptors and target analyte,
and lableded affinity biosensor uses label molecular to help detect the target. For example,
fluorescence labeling[24],[25], radiolabeling or isotope labeling, etc. Introducing
microfluidics into POC systems attracts increasing interest and offers new ways and
methods for POC diagnostics[26]. ELISA (enzyme-linked immunosorbent assay)[27] is a
plate-based assay technique designed for detecting and quantifying substances such as
peptides, proteins, antibodies and hormones. A detection enzyme or other tag can be linked
directly to the primary antibody or introduced through a secondary antibody that recognizes
the primary antibody. Detection is accomplished by assessing the conjugated enzyme
activity via incubation with a substrate to produce a measurable product. Since the
traditional ELISA relies on diffusion of the reactants to the antibodies immobilized on the
microwell surface, the incubation times can be as long as a few days per assay. A strategy
to reduce the assay time lies in reducing the well volume while increasing its surface area,
which leads directly to miniaturization and microfluidic integration[28]–[34].
Microfluidics can improve the sensitivity, speed, and reduce costs of an immunoassay over
ELISA by overcoming the issues of the large sample volume, long assay duration and low
sensitivity. By employing a bead-based immunoassay in a microfluidic channel, Sato et al.
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reported to shorten an immunosorbent assay overall time from 24 hr to less than 1 hr with
a limit of detection of 1 µg/ml[35]. To lower the cost of the sensing platform, Microfluidic
Paper-based Analytical Devices (µPADs)[36], [37] is another option. Paper itself has
advantages like being inexpensive, flexible, light weight, disposable, compatible with
biological samples, and can be easily modified by chemicals. Since capillary force in wet
paper could be the mainly driving force for fluids flow delivery, complicated supporting
pump is not necessary. This allows biosensors to be more readily transformed in lab-on-achip with capillary microfluidics[38]. Nevertheless, drawbacks like low limit of detection
and sensitivity, immaturity of paper based devices and losing activity of bioreceptors with
time limit the application of µPADs.

2.3 Label-free affinity biosensors
Labeled biosensors require a label attached to the target for signal amplification
purposes and during readout the amount of label is detected and assumed to correspond to
the number of bound targets. However, steps such as labeling a biomolecule would increase
the complexity and time of sensor operation, drastically change its binding properties, and
the yield of the target-label coupling reaction can be highly variable[39]. Being label-free,
thus eliminating the need for labeling (fluorescent, chemical, or radioisotope) target
molecules, is important.
Surface plasmon resonance (SPR)[40],[41] based label-free biosensor can be
utilized to detect bioparticles reactions such as protein binding[42],[43] and hybridization
of different types of nucleic acids[44]. Figure 1[45] shows the configuration of an SPR
device. The surface plasmons (SPs) is a free charge oscillation that exist at the interface
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Figure 1 Configuration of an SPR device. SPR’s wave-matching condition is very easily
disrupted by even very tiny changes in the interface conditions.[45]

10
between any two materials[46]. A fraction of the light energy incident at a sharply defined
angle can interact with the delocalized electrons in the metal film (plasmon) thus reducing
the reflected light intensity. In Figure 1, a single wavelength laser beam enters a prism
which results in many light angles striking the metal surface, all of them are reflected
except for the angle in which the metal will absorb and turn its energy into a plasmon wave
onto its outer surface, at this angle no light is reflected and thus appears with very little
intensity on the detector. Since the plasmon wave propagates on the outer side of the metal,
any interaction with the conjugated protein will change the resonance angle[45]. The SPR
biosensors have been widely applied in a diverse range of fields, including molecular
recognition, and disease immunoassays, etc.[47]–[52]
Impedance spectroscopy is another example of label-free strategy for transducing
biological recognition events[53]. It has been widely used for probing various types of
biomolecular interactions such as immunosensors, DNA hybridization, rapid biomolecular
screening, cell culture monitoring, etc.[54]–[57], since Newman and Martelet[58] who
come up with the concept of impedimetric based immunosensors. So far, impedimetric
immunosensors have been successfully applied at the academic level. However, no
prototypes have been released into the market and this fact has brought the reliability of
them into question.
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CHAPTER 3
AC ELECTROKINETICS
ACEK effects, including dielectrophoresis (DEP), ACEO and ACET effects, are
increasingly used in microfluidic devices to manipulate fluids and embedded objects[59].
DEP directly acts on the particles embedded in the fluid, while ACEO and ACET effects
induce fluid movements that carry the embedded particles. ACEK effects improve the
sensor sensitivity and response time by accelerating the travel of target molecules to the
electrode surface[25],[60],[61].

3.1 Dielectrophoresis
Dielectrophoresis, or DEP, refers to the interaction between a dipole moment on a
particle and a non-uniform field[62]. This technique has been studied in great details for
controlled manipulation of particles, binary separation, and characterization of particles.
The DEP force on a spherical particle can be described as followed[63],
∗ −𝜀 ∗
𝜀𝑝
𝑚

𝐹𝐷𝐸𝑃 = 𝜋𝜀𝑚 𝑎3 Re [𝜀∗ +2𝜀∗ ] ∇|𝐸|2 = 𝜋𝜀𝑚 𝑎3 Re[𝐾(𝜔)]∇|𝐸|2
𝑝

(3.1)

𝑚

∗
where 𝜀𝑚 is the medium permittivity, 𝑎 is the radius of the particle, 𝜀𝑝∗ and 𝜀𝑚
are particle

and medium complex permittivity respectively.
𝜎

Complex permittivity is defined as 𝜀 ∗ = 𝜀 − 𝑗 𝜔𝜀 (σ: conductivity; ω angular
frequency). 𝐾(𝜔), a function of ω, is also known as Clausius–Mossotti factor. Therefore,
the DEP force 𝐹𝐷𝐸𝑃 is frequency dependent. In the context of electrokinetic manipulation,
the real part of the Clausius–Mossotti factor is a determining factor for the dielectrophoretic
force on a particle. For Re[𝐾(𝜔)] > 0 (or < 0 ), 𝐹𝐷𝐸𝑃 > 0 (or < 0) and positive (or
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negative) DEP will be applied on the particle. Since positive DEP force on a particle traps
the particle at the surface of electrodes while negative DEP repels the particle away from
the electrodes, in this work, positive DEP would be applied to accelerate the binding
reaction between virus and antibody. As is shown in Equation 3.1, 𝐹𝐷𝐸𝑃 depends on the
particle volume. For nanoscale macromolecules, DEP may not be effective unless the
molecules are located within a very short distance to the electrodes (<1 mm).

3.2 AC Electroosmosis
ACEO effect can induce microfluidic vortices above electrodes to transport target
molecules to the electrode surface for binding[64]–[67], which improves the detection
sensitivity and response time. ACEO typically dominates at low ionic strengths, such as
target samples diluted in water. But the flow velocity of ACEO has been observed to
decrease significantly with increasing conductivity and eventually drop to zero above 0.085
S/m[68]. Hence for medical and biological applications involve the use of solution with
high conductivity the ACEO flow will be negligible. ACEO flows are caused by the
movement of induced charges in the EDL at the solid-liquid interface when a non-uniform
AC electric field is applied. The induced counter-ions will move under a tangential electric
field to generate ACEO flows. ACEO fluid velocity is approximately given as
𝑢𝐴𝐶𝐸𝑂 = −

𝜀𝑚
𝜂

∙ 𝛥𝜉 ∙ 𝐸𝑡

(3.2)

where 𝜺𝒎 and 𝜼 are the permittivity and viscosity of the medium, 𝑬𝒕 is the component of
the electric field strength tangential to the electrode surface, and 𝜟𝝃 is the voltage drop
over the interfacial layer including the EDL and molecular deposition at the electrode
surface[63]. ACEO velocity is known to exhibit a bell-shaped dependence on frequency
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due to the charging process of EDL. Therefore, the frequency of capacitive sensing needs
to be optimized to maximize ACEO effect.

3.3 AC electrothermal effect
ACET effect arises from uneven Joule heating due to an electric current flowing
through the fluid. Once the AC electric field is applied in the bulk solution, polarized
particles would be separated and migrate, which generates the ionic current. The time
average electric thermal force is shown in Equation 3.3,
∇σ

𝐹𝐸𝑇 = −0.5 [( σ −

∇𝜀
𝜀

𝜀𝐸

) 𝐸 1+(𝜔𝜏)2 + 0.5|𝐸|2 ∇𝜀]

(3.3)

where 𝐸 is the electric filed strength, 𝜔 is the frequency of the applied excitation, 𝜀 and σ
are medium permittivity and conductivity respectively, 𝜏 = 𝜀 ⁄σ is the charge relaxation
time.
Separation of the electrodes used in our tests is around 2 um, which leads to a quite
low ACET force that can also be neglected. As a result, the only dominated force for target
virus concentration is the DEP force, which is calculated to be 2.25×10−17 𝑁, leading to a
fluid velocity of 47.5nm/s.

3.4 Capacitive sensing
When immersed into fluid, the interdigitated electrode cell can be electrically
represented by an equivalent circuit. The circuit shown in Figure 2 consists of the
electrode’s self-resistance (Rwire), interfacial capacitance (Cint), charge transfer resistance
(Rct), solution bulk resistance (Rs) and dielectric capacitance of the electrode cell (Cs).
The interfacial capacitance is a combination of electric double layer (EDL) and deposited
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Figure 2 Equivalent circuit for a pair of sensor electrodes in fluid.
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bioparticles capacitance and is expressed as in Equation 3.4,
1

1

𝑝

𝑠

𝐶𝑖𝑛𝑡 = 𝐴𝑖𝑛𝑡 ⁄(𝜀 𝑑𝑝 + 𝜀 𝑑𝑒𝑑𝑙 )

(3.4)

where Aint is the surface area of the interfacial capacitor of the functionalized electrode, dp
and dedl are the thickness of bioparticle immobilized and electric double layer formed on
the electrodes surface respectively, εp is the bioparticle permittivity and εs is the solution
permittivity. When bioparticles are immobilized on the surface and binding reaction
occurs, dp will increase and therefore result to the interfacial capacitance to reduce.
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CHAPTER 4
ELECTRODES FOR DIRECT CAPACITIVE BIOSENSING
The sensing platform in this work is based on AC electrokinetics (ACEK)
capacitive sensing technology.[69] It adopts low cost interdigitated microelectrodes
functionalized with a capture bioreceptor targeting the pathogen bioparticles that need
detection. During the assay, an AC signal is applied onto the microelectrodes to induce
microfluidic phenomena by ACEK effects that cause targets in the sample solution applied
on electrodes to move towards the electrode surface and bind with the immobilized
bioreceptor. The binding causes a change in the interfacial capacitance (Cint) at sensor
surface, and is detected electrically using the same ACEK signal.

4.1 Various interdigitated electrodes
4.1.1 Surface acoustic wave (SAW) resonators
The Surface Acoustic Wave (SAW) electrode chips used in our ACEK capacitive
assay are modified from AVX Corps’ PARS 433.92 chip. The metal cover of the SAW
resonator is removed mechanically to expose the working electrode array for use, as shown
in Figure 3. The detection surface consists of aluminum electrodes deposited on quartz
substrate. Each electrode finger is 2.0 μm wide, 170μm long, with 1.5 μm spacing from
each other. The metal housing around the electrode chip is about 4mm (L) x 2.5mm (W) x
1mm (H), and accommodates ~10µL of sample. The interdigitated electrodes are
electrically connected to two contact pads on the chip bottom, which are then connected to
an impedance analyzer (Agilent 4294A).
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Figure 3 Commercially available Surface Acoustic Wave (SAW) electrode chip.
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4.1.2 Copper-based gold electroplated electrodes
The copper-based gold electroplated printed circuit board (PCB) electrodes shown
in Figure 4 are fabricated by chemical etching method. Electrode finger is 400 µm wide
and 200 µm in separation. Pattern of electrodes is printed on toner transfer paper in ink and
then transferred onto the copper sheet by using laminator whose temperature is set to be
379°F. After being slipped into water to release the paper from image picture, the board is
cleaned and dried, toner reactive foils are applied to seal the toner image against the etchant,
resulting in a perfectly etched image. With the ink sealed and protected by toner reactive
foils, the patented copper sheet is then immersed into copper etchant, or ferric chloride
(MG Chemicals), which is heated to 55°C (135°F). After etching the board, toner reactive
foils and underlying toner are removed by wiping down the board with Acetone.
4.1.3 Microfabricated gold electrodes
Microfabricated gold electrodes shown in Figure 5 are using lift-off method. 30 nm
gold layer is deposited on the 10 nm chromium adhesion layer and then the 500 nm silicon
dioxide layer. Each gold electrode finger is 4 µm wide and 4 µm spacing in between each
other.

4.2 Design consideration of interdigitated electrodes
The suitability of an IDE can be evaluated by extracting the equivalent circuit of
the IDE. Figure 6 shows the fitting of gold electrodes on silicon wafer and copper PCB
electrodes. A Warburg (Zw) is added in series with Rct in Figure 2 to represent the diffusion
effect in EDL for a better fitting of the circuit at low frequency. Fitted values are listed in
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Figure 4 Copper-based gold electroplated PCB electrodes by chemical etching.

Figure 5 Gold Electrodes on silicon wafer.

Figure 6 Equivalent circuit fitting of (a) gold electrodes on silicon wafer and (b) copper
electrodes fabricated by printed circuit board (PCB) etching.

20
Table 1, from which it can be seen that for the gold electrodes on silicon wafer, Cs and Cint
are comparable and both in nF level.
At the experimental frequency, which is 100 kHz, the circuit is expected to be
simplified into Cint in series with Rs only. In order to achieve that, XCint << XRct+Zw and XCs
>> Rs are expected. From the calculated reactance values listed in Table 1, for gold
electrodes on silicon wafer, XCs is not as greater than Rs as that of PCB copper electrodes.
Therefore, as what has been justified by experiments, gold electrodes showed quite poor
response that cannot correctly be associated with the occurrence of binding reactions. To
satisfy XCint << XRct+Zw and XCs >> Rs, Cint is required to be much greater than Cs. Expression
of Cint is given in Equation 3.4. Similarly, Cs is shown as follows:
1

𝑔

𝐶𝑠 = 𝐴𝑒𝑙𝑒𝑐𝑡𝑟𝑜𝑑𝑒𝑠 ⁄[𝜀 𝜋 ( 𝑠 + 𝜎𝑤)]

(4.1)

𝑠

where Aelectrodes is the electrodes area, g and w are the electrodes digit gap and width
separately, and σ, which is usually equal to 20%, is the percentage of the electrodes digit
width that is included in Cs. The Cint/Cs ratio can then be estimated as follows by
recalling Equation 3.4:
𝐶𝑖𝑛𝑡
𝐶𝑠

=

1
1
𝑑 + 𝑑 )
𝜀𝑝 𝑝 𝜀𝑠 𝑒𝑑𝑙
1
𝑔
𝐴𝑒𝑙𝑒𝑐𝑡𝑟𝑜𝑑𝑒𝑠 ⁄[ 𝜋( +𝜎𝑤)]
𝜀𝑠
𝑠

𝐴𝑖𝑛𝑡 ⁄(

1
1
𝑑 + 𝑑 )
𝜀𝑝 𝑝 𝜀𝑠 𝑒𝑑𝑙
𝑤𝑙 1
𝑔
⁄[ 𝜋( +𝜎𝑤)]
2 𝜀𝑠
2

𝑤𝑙⁄(

=

=

𝜋(𝑔+2𝜎𝑤)
𝑑𝑝 +𝑑𝑒𝑑𝑙

> 103

(4.2)

where l is the electrodes digit length. Since the EDL thickness and bioparticle in real
samples are both usually less than 100 nm, by using electrode in hundreds of micrometers
would result in the Cint/Cs ratio to be as high as 103, which also offers explanation as to
why gold electrodes on silicon wafer showed worse output response than the copper PCB
electrodes.
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Table 1 Equivalent circuit fitting for gold electrodes on silicon wafer and copper PCB
electrodes (Reactance calculated at 100 kHz).
Element

Silicon Wafer
[Gold]

PCB
[Copper]

Rwire

5Ω

8Ω

Rct

3400 Ω

36 Ω

Zw

100 Ω∙S-0.5

1.3 MΩ∙S-0.5

XRct+Zw(calculated)

3.4 kΩ

1.666 kΩ

Cint

35 nF

20nF

XCint(calculated)

45.47 Ω

79.57 Ω

Rs

18 Ω

800 Ω

Cs

3.3 nF

5.1 pF

XCs(calculated)

482 Ω

0.31 MΩ

22

4.3 Electrodes surface treatments
For the metal electrodes such as SAW chips and copper PCB electrodes, prior to
incubation with linker and probe molecules, the microelectrode chips is thoroughly
cleaned by washing with acetone, isopropyl alcohol and deionized water, and then treated
with ozone or plasma. The surface quality is closely monitored by measuring the Cint. As
for the laser printed electrodes, due to the multiscale morphology of the irradiated
polyimide surface, wetting properties of interfacial capacitance sensors have become
particularly important. The static contact angle of untreated polyimide is found to be
79±1°(Figure 7(a)), consistent with previous reports[70]. After laser ablation, the contact
angle is increased to 99±1°(Figure 7(b)). Based on the microstructure characterization,
this hydrophobicity can be attributed to both the carbonization and porous surface
structure.
However, in most cases this hydrophobic character is not desirable for sensors,
especially for detection in an aquatic medium. Plasma treatment is a good method for
increasing the surface hydrophilicity by creating OH dangling bonds and enriching O- ions
on the surface without influencing the electrode microstructure characteristics. After 10
minutes of vacuum plasma treatment (PLASMA ETCH PE-50), the water drop completely
infiltrates into the electrode surface (Figure 7(c)), indicating a marked surface transition
from hydrophobicity to hydrophilicity. Besides plasma treatment, ozone treatment can also
improve the hydrophilicity of the electrode surface by enriching O- ions on the surface. So
three types of surface treatments are investigated, including ozone at 15 min, 30 min and
plasma at 5 min.
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Figure 7 A drop of deionized water (3 μL) on (a) pristine and (b) irradiated polyimide
surfaces and (c) the irradiated polyimide surface after plasma treatment. (d) Electrodes
with a mini-chamber and two Cu foil leads attached. (e) Sensor responses with different
ozone surface treatments.
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The ultimate criterion of surface treatment for biosensor is to obtain sensitive
response. So BPA samples at concentrations of 0.1 fM, 1 fM and 10 fM are applied to the
sensors. The sensor response for each treatment is shown in Figure 7(e). It can be seen that
the plasma treated sensors consistently have higher response than ozone treated sensors,
regardless of treatment time. This means that the immobilization efficiency of sensors
treated with plasma is improved since more aptamer attached to the electrode surface made
the surface less likely to become saturated (responses to 10 fM BPA showed significant
difference between plasma and ozone treated sensors). In conclusion, the plasma treated
sensor exhibits large responses even in the limit of high PBA concentration, yielding a
combination of high sensitivity and large dynamic range.
The electrode’s functionalization after plasma treatment includes receptor
incubation and uncovered surface blocking. As the incubation and blocking processes
progressed, an increasing number of molecules become attached to the electrode surface.
The quality of electrode functionalization is monitored by measuring the Cint. This method
is validated in our prior work [71]. During the incubation and blocking process, Cint values
have reduced by -58.05±3.19% and -93.35±2.06% respectively for BPA, indicated
adequate molecular immobilization on the electrode surface. Surface immobilization
reduces the current flowing through the electrodes, effectively increasing the charge
transfer resistance, Rct. Therefore Rct is also measured during the incubation and blocking,
which showed an increasing Rct with time as shown in Figure 8.

4.4 Measurements and data analysis
This work uses ACEK-based capacitive sensing to monitor the molecular
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Figure 8 Cyclic voltammetry characteristics of sensor’s (a) incubation and (b) blocking
process.
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deposition at the electrolyte/electrode interface. Prior work demonstrates that interfacial
capacitance (Cint) can effectively detect molecular deposition on the electrode surface with
high sensitivity and specificity[69],[72],[73]. In ACEK capacitive sensing, Cint is found by
measuring the sensor cell’s impedance at a fixed AC frequency and voltage continuously
during the testing. The interfacial capacitance of the electrodes is sampled and recorded
periodically by an Agilent 4294A impedance analyzer for 20 seconds. Then the percentage
change, dC/dt in %/min, of the measured capacitance is adopted as the readout of the sensor,
indicating the binding reaction occurring on the electrodes surface. Least square linear
fitting algorithm is performed to determine the capacitance change rate.
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CHAPTER 5
IMPROVEMENT AND OPTIMIZATION
5.1 Cross linker for immobilization of protein probe
5.1.1 Reagents and samples
5.1.1.1 Protein IgG
Sample solution uses 0.1×PBS (1 mM phosphate-buffered saline [pH 7.0]
containing 15 mM sodium chloride) with a conductivity of 0.15–0.16 S/m (600–700 Ω∙cm)
as standard buffer for sample diltuion. 1mg/mL KKKKKAAAC cross linker is prepared
by adding 1.2 mg KKKKKAAAC cross linker (New England Peptide, Gardner, MA) into
1.2 mL ultrapure water. The probe used for electrodes functionalization is 10 µg/mL bovine
IgG whole molecule, which is 1:1000 dilution of 10 mg/mL bovine IgG whole molecule
(Johnson ImmunoResearch, West Grove, PA) in ultrapure water. 1×101 to 1×106 fg/mL
goat anti-bovine IgG antibody samples are obtained by diluting 2 mg/mL goat anti-bovine
IgG antibody (Johnson ImmunoResearch) with 0.1×PBS. 100 µg/mL lactoalbumin is used
for blocking, which is 1:10 dilution of 1mg/mL lactoalbumin (Sigma-Aldrich, St. Louis,
MO) stock solution in ultrapure water. 4 µg/mL BSA, or bovine serum albumin protein, is
prepared as interference by adding 40 µg BSA (Sigma-Aldrich, St. Louis, MO) in 10 mL
0.1×PBS.
5.1.1.2 Influnza A virus
Sample solution in this work is prepared using the same 0.1×PBS and 0.1×PBS-T
as described for protein detection tests. 0.1×buffer B is 0.1×PBS-T containing 10 v/v%
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SuperBlock (Pierce Biotechnology, Rockford, IL) and is used as the blocking reagent. The
chemical linker used for improving surface functionalization with antibody is 10 v/v% 3aminopropyltriethoxysilane (APTES, Thermo Scientific, Waltham, MA) in absolute
ethanol and 2.5% glutaraldehyde in water. Antibody solution used for electrodes
functionalization is 41.5 µg/mL anti-influenza A antibody in distilled water.
Antibody for electrodes functionalization is 1:100 dilution of 4.15 mg/ml antiinfluenza A antibody (gift from a company) in distilled water to a concentration of 40
µg/ml. Antibody for dummy electrodes is 40 µg/ml bovine IgG whole molecule (Code#
001-000-003, Johnson ImmumoReserch, West Grove, PA), diluted from 10 mg/ml in
distilled water. Spiked Influenza A virus sample is 1:100, 1:1,000 and 1:10,000 dilution of
0.1525 mg/ml influenza A virus (a gift from a company) in 0.1×PBST to concentrations of
1.525 µg/ml, 0.1552 µg/ml and 0.01525 µg/ml.
5.1.2 Performance of sensors with cross linker modification
As shown in Figure 9, 10 fg/mL, 100 fg/mL and 1 pg/mL goat anti-bovine IgG
antibody spiked in 0.1×PBS are tested. Each concentration is tested in triplicate and their
results are -3.07±0.59 %/min (10 fg/mL), -6.08±0.47 %/min (100 fg/mL) and -11.17±1.07
%/min (1 pg/mL), while the responses of the buffer solution 0.1×PBS and non-specific
interference 4 µg/uL BSA are -0.10±0.46 %/min and 0.099±0.44 %/min respectively.
Dummy electrodes coated with 4 µg/uL BSA are also tested with 100 fg/mL and 1 ng/mL
goat anti-bovine IgG antibody samples, which show very small responses (-0.47±0.71
%/min and -1.13±0.46 %/min) compared with functionalized electrodes, indicating that the
responses from active sensors are indeed due to the binding between the probe and the
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Figure 9 Response of 0.1×PBS, 4µg/uL BSA and 10 fg/mL, 100 fg/mL and 1 pg/mL
goat anti-bovine IgG antibody samples on electrodes functionalized with probe, in
addition to 100 fg/mL and 1 ng/mL goat anti-bovine IgG antibody samples on dummy
electrodes coated with BSA. Inset is dose response of sensor electrodes without APTES
modification.
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analyte. The dependence of dC/dt on analyte concentration is approximated by linear fitting
as 𝑦 = −3.69654 ∙ lg𝑥 + 0.92916 where x is the analyte concentration in fg/μL and y is
the capacitance change rate, d|C|/dt, in %/min. The LOD is defined as 3 standard deviations
from the response of the background control. Because the background produced a response
of -0.10±0.46 %/min, the cut-off d|C|/dt is calculated to be -1.49 %/min, which corresponds
to 4.513 fg/mL goat anti-bovine IgG antibody. Dose response of electrodes without APTES
modification is investigated in previous work[73], and it is shown in the inset of Figure 9.
The responses are quite small and the data points are in ‰/min instead. In the tests with
electrodes functionalized with passive adsorption of probe protein, the IgG antibody
concentration ranges from 0.2 ng/mL to 10 ng/mL, and the tests of every IgG antibody
concentration are also repeated three times using a new electrode each time. The responses
for IgG antibody samples are -0.02±0.13 ‰/min at 0.2 ng/mL, -3.07±0.38 ‰/min at 0.5
ng/mL, -5.09±0.38 ‰/min at 1 ng/mL, and -6.93±0.56 ‰/min at 2 ng/mL respectively.
Using an AC signal of 1 Vrms AC voltage with a duration of 10 min, an LOD of around 1
ng/mL is reached.
Dose response of influenza A virus samples in various concentrations (15.25
pg/mL, 152.5 pg/mL, 1.525 ng/mL, 15.25 ng/mL and 152.5 ng/mL) is shown in Figure 10.
Tests are firstly conducted on the electrodes functionalized with bioreceptors by passive
adsorption (i.e. without chemical linkers between electrodes and bioreceptors) and the
results (blue data points) demonstrate very low outputs from the sensor (-0.5124±0.2101
%/min, -0.7529±0.1813 %/min, -0.7451±0.3147 %/min, -0.8126±0.4214 %/min for 0.1525
ng/mL, 1.525 ng/mL, 15.25 ng/mL and 152.5 ng/mL influenza A virus in 0.1×PBST
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Figure 10 Dose response of influenza A samples as a function of concentration. Tests
conducted on electrodes modified with APTES chemical linker (black) yields a linear
correlation between sensor output and sample concentrations with an LOD of 0.2513
pg/mL. Tests conducted on electrodes treated with passive functionalization method
(blue) demonstrates very small responses.
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respectively). In contrast, the sensor’s responses are significantly improved by modifying
electrodes with APTES before bioreceptors immobilization. Shown as the red data points
in Figure 10, the averaged responses of dC/dt are -2.72±0.34 %/min for 15.25 pg/mL virus
sample, -3.67±0.37 %/min for 152.5 pg/mL, -5.06±0.29 %/min for 1.525 ng/mL, 6.46±0.64 %/min for 15.25 ng/mL and -7.59±0.46 %/min for 15.25 ng/mL. Reponses of
control tests and dummy electrodes are 0.18±0.19 %/min and 0.73±0.23 %/min
respectively, which can be easily differentiated from the responses of functionalized
electrodes. The dose response can be fitted by Equation 4.1 with a correlation coefficient
(R2) of 0.994.
𝑑𝐶
𝑑𝑡

(%/min ) = −1.236 ∙ lg(𝑥 (ng/mL)) − 4.855

(4.1)

where x is sample concentration in ng/mL.
LOD is defined as three times the standard deviations (0.5816 %/min) from the
background response, which is 0.1×PBS-T (0.1769 %/min). The LOD, also the threshold
value for differentiating the positive samples from the negative, is calculated to be -0.4048
%/min which corresponds to 0.2513 pg/mL influenza A virus.

5.2 Immobilization buffers
5.2.1 Reagents and samples
5.2.1.1 Zika RNA Washing buffer and blocking reagent
0.5×SSC buffer is prepared by 1:40 dilution of AccuGENE™ 20×SSC Buffer
(Lonza, Rockland, ME USA) in ultrapure water. Blocking solution is 1.0 mM 6mercaptohexanol (Sigma-Aldrich, St. Louis, MO) prepared in ultrapure water. A 5’-thiol-
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modified oligo probes, 5’-TTTCGCTCTATTCTCATCAGTTTCATGTCCTGTGTC-3’,
is synthesized by Fisher Thermo, which is then suspended in DNase/RNase free water to
reach a concentration of 100 μM. The probe has a 100% match with Zika virus American
Strain with a target region of 1373-1408. It has 26 out of 36 nucleotides matches Zika
Uganda strain (targeting Uganda region 1433-1462). DNA probes are diluted to 20 μM in
0.05×PBS.
5.2.1.2 Human herpes virus-1 dsDNA
Testing buffer is based on 20× saline-sodium citrate (SSC) buffer and then diluted
to make 2×, 1× and 0.5×SSC in ultrapure water. 5’ thiol-modified human herpesvirus 1
probe (HSV-1, 5’- CAAGGCTCACGTGCGAGAGAGCCTCCTC -3’)[74] is designed to
specifically target UL30 gene of HSV-1, which is then prepared in DNAse/RNAse free
water at a concentration of 20 μM. Genomic dsDNAs of Human herpesvirus 1 (HSV-1,
Strain McIntyre, ATCC® VR-539D, ATCC, Manassas, VA) and Human herpesvirus 2
(HSV-2, Strain G, ATCC® VR-734, ATCC, Manassas, VA) are prepared in ultrapure
water at concentration of 36 μg/mL and 1.3 μg/mL respectively, as stock sample solution.
5.2.2 Sensor performance with various immobilization buffers
Various immobilization buffers (buffers that probe are diluted in for electrodes
functionalization) and testing buffers (buffers that target nucleic acid are diluted in for
detection) can lead to various sensor performances[75]. Therefore, multiple tests of Zika
virus RNA and HSV-1 DNA detections are conducted to define the roles these buffers play
in detections. In Figure 11, tests of 18.76×103 copies/μL Zika virus RNA sample are
conducted on chips with probes prepared in different buffers which would affect the
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Figure 11 Tests of 18.76×103 copies/μL Zika virus RNA sample are conducted on chips
incubated with probes prepared in ultrapure water, 0.05×PBS and 1×PBS. Probes in
0.05×PBS is considered to be the optimal due to its high response.
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electrodes surface functionalization. Ions in the buffer screen the electrical charges of
nuclei acids and allow for higher coverage of electrode surface during immobilization.
However, too much ions will cause nuclei acids to coil and lose the ability to bind with
other molecules. Buffers of various ionic strengths, including ultrapure water, 0.05×PBS
and 1×PBS, is used to functionalized the sensors, and the resultant sensors yield responses
of 6.09±0.70 %/min, 7.52±0.78 %/min and 3.02±1.83 %/min, respectively. Clearly, probe
in 0.05×PBS leads to the highest response and therefore is used as the optimal
immobilization buffer in subsequent experiments.
Further, dose responses of HSV-1 DNA probe in water and 0.05×PBS are obtained
and demonstrated in Figure 12. With HSV-1 DNA sample diluted in 0.5×SSC, utilizing
0.05×PBS as buffer for probe incubation (black) gives sensor better performance than
ultrapure water (blue). This is because, compared to ultrapure water, 0.05×PBS contains
more ions and is able to screen the electrical charges of nuclei acids. It can facilitate probe’s
immobilization on the surface by allowing for higher coverage of electrodes surface during
immobilization.

5.3 Testing buffers
Next, for the testing buffers, similarly, Zika virus RNA and HSV-1 DNA are also
utilized for testing. Three concentrations of Zika virus RNA from 187.6 copies/μL (1.0
pg/mL) to 18,760 copies/μL (100 pg/mL) are tested in triplicate with a new functionalized
sensor each time. Three concentrations are spiked in 0.5×SSC and 1×SSC solution
respectively and tested three times using prepared sensors. Their d|C|/dt responses and
standard deviations are shown in Figure 13. The three samples are clearly differentiable
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Figure 12 Evaluation of sensor’s performances when probe is prepared in 0.05×PBS and
ultrapure water. Probe prepared in 0.05×PBS and DNA samples in 0.5×SSC (black) is the
optimal immobilization buffer with an LOD of 0.986 pg/mL (6.38 copies/μL or 0.0106
fM).

Figure 13 Dose response of Zika RNA spiked in 0.5×SSC and 1×SSC for testing buffer
evalution. 0.5×SSC is considered to be the optimal testing buffer and d|C|/dt is 2.40±0.50
%/min for 187.6 copies/μL (1 pg/mL), 5.19±1.12 %/min for 1,876 copies/μL (10 pg/mL)
and 7.52±0.78 %/min for 18,760 copies/μL (100 pg/mL), showing a clear logarithmic
dependence on Zika virus RNA. Its LOD in 0.5×SSC is yielded to be 0.986 pg/mL
(78.825 copies/μL) with a response of 1.458 %/min.
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from the background, and their response has a logarithm dependence on concentrations.
However, by comparing the slopes of these two curves, target RNA prepared in 0.5× SSC
reveals it superiority to the target in 1×SSC. For tests with Zika virus RNA in 0.5×SSC as
testing buffer, d|C|/dt is 2.40±0.50 %/min for 187.6 copies/μL (1.0 pg/mL), 5.19±1.12
%/min for 1,876 copies/μL (10 pg/mL) and 7.52±0.78 %/min for 18,760 copies/μL (100
pg/mL). The dependence of d|C|/dt on Zika virus RNA concentration can be approximated
fitted as 𝑦 = 2.56978 ∙ lg𝑥 − 3.41633, where x is the Zika virus RNA concentration in
copies/μL and y is the capacitance change rate, d|C|/dt, in %/min. The LOD is 78.825
copies/μL, or 0.4222 pg/mL, which is defined as 3 standard deviations from the response
of background control (0.53±0.31 %/min). The corresponding cut-off d|C|/dt is calculated
to be 1.458 %/min.
In a separate experiment, Dengue virus type 2 RNA (New Guinea strain) of 1 ng/ml
(190,850 copies/μL) is suspended in both 0.5×SSC and 1×SSC and tested as interference,
yielding responses of 3.02±0.35 %/min and 4.78±0.80 %/min respectively. So, given the
performances on sensitivity and specificity, 0.5×SSC is used as the optimal testing buffer
for Zika virus RNA sample dilution.
As for testing HSV-1 DNA in different testing buffers, as shown in Figure 14, either
with 0.05×PBS or ultrapure water for electrodes’ functionalization, DNA samples diluted
in 0.5×SSC always show higher responses than those in 2× SSC or 1× SSC. It is easy to
conclude that buffer used for DNA sample dilution with a relatively low conductivity yields
high responses. This is because that relatively low fluid conductivity can result in strong

38

Figure 14 Evaluation of sensor’s performances when HSV-1 virus DNA is prepared in
0.5×, 1× and 2×SSC. Probe prepared in 0.05×PBS and DNA samples in 0.5×SSC (black)
is the optimal immobilization buffer with an LOD of 0.986 pg/mL (6.38 copies/μL or
0.0106 fM).
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DEP effect. In Equation 3.1, lower fluid conductivity gives greater Clausius–Mossotti
factor value. Thus, bioparticles in low fluid conductivity will have high DEP velocity.
Based on the given results in Figure 14, HSV-1 probe in 0.05×PBS and HSV-1
DNA (target), HSV-2 (interference) in 0.5×SSC are considered to be optimal with
responses of -3.90±0.52 %/min (9 pg/mL), -6.92±0.94 %/min (90 pg/mL) and -9.72±0.63
%/min (900 pg/mL). The sensor’s LOD is defined as 3 standard deviations from the
response of the background control (-0.22±0.30 %/min), so the cut-off d|C|/dt is calculated
to be -1.12 %/min, which corresponds to a HSV-1 DNA concentration of 0.986 pg/mL
(6.38 copies/μL or 0.0106 fM). Tests of interference (HSV-2 DNA) also demonstrate a
good specificity with a low response of -0.19±0.60 %/min at a concentration (5 ng/mL)
550 times higher than that of HSV-1.

5.4 Applied AC signal frequency and voltage
To elucidate the effects of ACEK mechanisms on detection, the first set of
experiments is to find out the effect of AC frequency on the sensor response. Based on
Equation 3.1, DEP effects are frequency-dependent. AC signals of various frequencies at
10 mV are used to measure the capacitance changes from influenza A virus samples at a
concentration of 1.525 ng/mL. The measured capacitance change rates are given in Figure
15(a). The response shows a bell-shape dependence on AC frequency, with its optimal
frequency between 50 kHz and 100 kHz, which indicates that the DEP is the dominant
enrichment mechanism. Consequently, AC signal at 100 kHz is considered as the
optimized frequency.
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Figure 15 Responses of 0.1×PBS-T, 1.52 ng/mL influenza A virus on functionalized
electrodes, and 152.5 ng/mL influenza A virus sample on dummy electrodes (a) when
using 10 mV AC signal with its frequency varied from 20 kHz to 200 kHz and (b)when
using 100 kHz AC signal with its voltage varied from 5 mV to 100 mV. (c) Responses of
50, 500 and 5000 pg/mL HSV-1 virus DNA and 5000 pg/mL HSV-2 virus DNA.
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Next, AC voltages varying from 5 mV to 100 V are used to measure 1.52 ng/mL
influenza A virus sample on functionalized electrodes. The background blank buffer, which
is 0.1×PBS-T, is also tested on the functionalized electrodes from 5 mV to 100 V as control.
Negative control experiments with 152.5 ng/mL influenza A virus sample are measured
under the same voltage conditions on dummy electrodes (electrodes without antibody).
Experiments with each voltage are repeated three times.
As shown in Figure 15(b), responses of the 0.1×PBS-T control samples on
functionalized electrodes and 152.5 ng/mL influenza A virus sample on dummy electrodes
remain quite small through the voltage range of 5-100 mV, with a limited response ranged
from -0.14 to -0.24 %/min and 1.02 to -0.01 %/min. For tests on functionalized electrodes,
due to DEP effect, the capacitive response decreases as the voltage increases from 5 to 100
mV, indicating that more binding takes place with higher AC voltage. When the voltage
level is above 10 mV, the increase of sensor’s response becomes limited due to saturation
of binding sites on the sensor. Therefore, 10 mV is chosen as the measuring voltage. At
this voltage, DEP effect will be weak for particles smaller than virus such as protein to
cause appreciable capacitance change[69], therefore improved the sensor specificity in
complex matrix. This can also be justified by the tests of HSV-1 virus DNA conducted
under 10 mV and 25 mV in Figure 15(c). While the sensor yields higher outputs at 25 mV,
the sensor also shows non-negligible responses (-1.87±0.43 %/min) to 5 ng/mL HSV-2
DNA. In contrast, the response of 5 ng/mL HSV-2 DNA is 1.21±0.31 %/min at 10 mV,
which is considered to a negative response as it cannot be differentiated from that of the
background. A good sensor requires the sensor to have large responses to target molecules
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with little to none responses non-targets. Test results of HSV-1 and HSV-2 indicate that
using AC signal at 10 mV can achieve good specificity with only slight compromise on
response (dC/dt values). Therefore, 10 mV is also considered to be superior to 25 mV in
detection of HSV-1 virus DNA.

5.5 Summary of the sensing platform’s performances
For the four different pathogen targets in standard matrices studied previously,
Table 2 summarizes their assay time, LODs, and matrices in which the LODs are obtained.
The performances of the biosensing platform in this work are significantly improved. It
can detect specific targets within 30 seconds, with quite low LODs in pg/mL or fg/mL
levels. The sensor also demonstrates good specificity against other interferences, which
make it has a great potential to be used for testing in complex sample matrices.
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Table 2 Summary of the sensing platform’s performance on detecting various
pathogens.
Target

Matrix

LOD

Assay time

influenza A virus

0.1×PBS-T

0.25 pg/mL

30 seconds

protein IgG/pseudorabies

0.1×PBS

4.5 fg/mL

30 seconds

DNA/Human herpesvirus 1

0.5×SSC

0.986 pg/mL

30 seconds

RNA/Zika

0.5×SSC

1 pg/mL

30 seconds
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CHAPTER 6
VARIOUS APPROACHES FOR PATHOGENS DETECTION IN
COMPLEX MATRICES
6.1 Influenza A virus
Clinical nasal swab Influenza A virus sample with nasal swab is immersed in
M4RT[76] are provide by a company and a serial dilution up to 1:10000 is applied using
0.1×PBST. It is common practice to dilute clinical samples in standard buffer. Due to the
complexity of clinical samples, highly diluted samples can reduce non-specific binding,
which improve the selectivity of the sensor. With more dilution of clinical samples, chances
of false positive results can be reduced. However, sensor’s sensitivity will also suffer since
the concentration of target particles is reduced at the same time. The optimization dilution
factor helps to decide which dilution can be used for the bind tests of unknown swab
samples in the next step. In addition, unlike the spiked samples in previous sections, clinical
swab samples are in M4RT instead of 0.1×PBS-T. M4RT is a liquid medium commonly
used in the transport of clinical specimens to the laboratory for qualitative microbiological
procedures for viral and chlamydial agents. M4RT with no dilution can cause a decrease
in capacitance (-0.48±0.035 %/min), but for M4RT with 1:1,000 dilution or more in
0.1×PBS-T its effect can be neglected (0.46±0.45 %/min at 1:1000 dilution). So dilution
factors higher than 1:1000 are studied in Figure 16. To find out the optimal dilution factor
to test, two clinical nasal swab samples (one positive and one negative) at various dilution
factors from 1:100,000 to 1:1,000. Each sample is tested in triplicates, and each chip is
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Figure 16 Responses of clinical negative and positive swab samples of dilution factor of
1:100,000, 1:10,000 and 1:1,000.
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tested with three dilutions in the sequence of 1:100,000, 1:10,000 and 1:1,000. Based on
the sensor’s readout in Figure 16, response reaches the highest at 1:10,000 dilution of
positive sample. The 1:1000 dilution did not yield a larger response due to the saturation
of the limited available binding sites on the electrode’s surface. Nevertheless, 1:100,000
dilution is adopted instead of 1:10,000 since the response of sample at 1:100,000 dilution
(-4.09±2.06 %/min) is located around the median of the dose response line shown in Figure
10. So 1:100,000 dilution is chosen in order to acquire a larger dynamic range in sensor
response, desirable for clinical swab samples measurement in blind tests.
Blind tests for a panel of 20 nasal swab samples (10 positive, 10 negative) are
conducted. All samples are 1:100,000 diluted with 0.1× PBS-T. The threshold value is set
at -0.40 %/min, which is also the LOD from previous tests with spiked samples, meaning
that samples with a response more negative than -0.40 %/min will be considered as positive
samples and others negative. As shown in Figure 17(a), 9 out of 10 positive and 7 out of
10 negative samples are correctly identified by ACEK capacitive sensors. A negative
sample with influenza B virus is also correctly identified. All these samples are verified by
RT-qPCR, yielding a sensitivity of 90% and specificity of 70% for the panel. Figure 17(b)
shows a positive correlation between the capacitance change rate and PCR cycles number.
Weak positive samples are chosen for this set of experiments. Among all the detected
positive samples, only the sample with the highest response can be detected by a
commercial RIDT, which corresponds to 22 PCR cycles. ACEK capacitive sensor can
detect virus level corresponding to 35 PCR cycles. There is a false negative corresponding
to 29 PCR cycles. This is possibly due to error during dilution or the binding site on the
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Figure 17 Comparison of results from ACEK capacitive sensors and those from
commercial tests for a blind panel test of influenza virus A from nasal swabs. (a)
Responses of all tested samples differentiated by the -0.40 %⋅min-1 cut-off line (blue) and
(b) correlation between PCR cycles and responses of samples determined as positive by
ACEK capacitive sensor in blind tests. The strongest positive sample is the limit of a
commercial rapid influenza test.
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virus not being exposed.

6.2 Protein (antibody to pseudorabies virus)
Serum spiked goat anti-bovine IgG antibody samples are tested to demonstrate the
sensor’s performance in complex matrix. HyClone™ Fetal Bovine Serum (U.S.), Standard
(FBS) is purchased from Fisher Scientific, Waltham, MA. It is then 1:10 and 1:100 diluted
in 0.1×PBS-T to obtain 1:10 and 1:100 FBS solution respectively for preparing of goat
anti-bovine IgG serum spiked samples. In order to gauge the effect of FBS matrix at various
frequency, 1:10 and 1:100 FBS are tested under the applied AC signal ranges from 20 kHz
to 200 kHz in Figure 18(a). The sensor response is found to decrease with increasing
frequency for both 1:10 and 1:100 FBS. However, 1:100 FBS demonstrate essentially
lower responses than 1:10 FBS. Therefore, dose response of protein in serum matrix is
studied by spiking goat anti-bovine IgG into 1:100 FBS at concentrations of 10, 100 and
1000 fg/mL in Figure 18(b).
Next, pseudorabies virus clinical samples, three positive and three negative, are
tested. The swab samples are diluted 1:10,000 v/v% in 0.1×PBS-T solution, which.
contains 0.05 v/v% Tween 20 (Fisher Scientific, Pittsburgh, PA), Positive samples can be
clearly differentiated from negative samples in Figure 19.

6.3 Nucleic acids RNA and DNA
6.3.1 Reagents
Human blood samples are collected from pregnant women who entered labor and
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Figure 18 (a) Responses of FBS in different dilution rates. (b) Dose response of protein
IgG in 1% serum matrix.

Figure 19 Tests of pseudorabies virus clinical samples. Positive and negative samples
can be clearly differenced.
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delivery at the University of Tennessee Medical Center, Knoxville. All samples andclinical
information are collected under clinical research protocols approved by the University of
Tennessee Institutional Review Boards. These human blood samples are centrifuged at
2,000 rpm for 15 minutes and sera are pooled. After being diluted 1:100 in 0.1×PBS, the
obtained 1% serum sample is then 1:1 mixed with lysing solution, which contains 1 mM
Tris (pH 8.0), 2 mM EDTA, 1% SDS and 2 mg/mL Proteinase K (Fisher BioReagents,
Pittsburgh, PA).
Quantitative genomic RNA from Zika virus is purchased from ATCC (ATCC®
VR-1838DQ, ATCC, Manassas, VA) and diluted in serum/lysing solution to 0.1876×103
copies/μL (1.0 pg/mL), 1.876×103 copies/μL (10 pg/mL), 18.76×103 copies/μL (100
pg/mL), 187.6×103 copies/μL (1 ng/mL) and 1876×103 copies/μL (10 ng/mL),
respectively. Quantitative genomic DNA from human herpesvirus 1 (HSV-1) (ATCC®
VR-539DQ™, ATCC Manassas, VA) is diluted in serum/lysing solution for a
concentration of 6.585×103 copies/µL (1 ng/mL). Dengue virus type 2 (New Guinea strain)
is diluted in serum/lysing solution to 19,095 copies/µL (0.1 ng/mL) respectively. Influenza
A virus (gift from a company) is suspended in serum/lysing solution to 1.525 ng/mL
6.3.1 Zika virus RNA
Five concentrations of Zika virus RNA are spiked in 1:1 mixture of 1% serum and
lysing solution, and tested using functionalized sensors. Each concentration is tested in
triplicates with a new chip each time. Like the samples spiked in 0.5×SSC, five Zika virus
RNA spiked serum samples are clearly differentiated from each other and the background.
As shown in Figure 20, d|C|/dt is 2.04±0.22 %/min for 0.1876×103 copies/μL (1.0 pg/mL),
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Figure 20 Responses of non-specific nuclei acid (HSV-1 and dengue) and virus
(influenza A), and dose response of Zika virus RNA spiked in serum/lysing solution.
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gradually increasing to 7.77±0.45 %/min for 1,876×103 copies/μL (10 ng/mL) RNA.
d|C|/dt shows a clear logarithmic dependence on Zika virus RNA concentration over at
least four orders of magnitude from 1.0 pg/mL to 10 ng/mL. The dependence of d|C|/dt on
Zika virus RNA concentration can be approximated as y=1.99369∙lgx-2.59808, where x is
Zika virus RNA concentration in copies/μL and y is capacitance change rate, d|C|/dt,
in %/min. The fitted line had a correlation coefficient of 0.97, and is used as the sensor
standard curve. The LOD is defined as 3 standard deviations from the response of the
background control. Because the background produced a response of -0.39±0.72 %/min,
the cut-off d|C|/dt is calculated to be 1.786 %/min, which corresponded to a Zika virus
RNA concentration of 158.1 copies/μL, or 0.846 pg/mL. The LOD of Zika virus RNA in
serum is slightly higher than that of RNA in SSC (78.8 copies/μL), which is expected due
to more interference molecules in serum. To exclude possible artifacts as causes of sensor
response, control tests are conducted by applying Zika virus RNA samples of the same
concentrations on dummy electrodes (without functionalization, and only blocked with 1.0
mM 6-mercaptohexanol in ultrapure water). As shown in Figure 20, the responses from the
dummy electrodes are negligible, at -0.092±0.12 %/min, -0.23±0.43 %/min,
0.38±0.39 %/min, 0.35±0.13 %/min and 0.51±0.12 %/min respectively, which are very
similar to the response of fluid background. This indicates that the responses from active
sensors are indeed caused by the hybridization between the probe and the target RNA.
In Figure 21, with the same lysing solution containing 1% serum, sensors
functionalized with three different probes are tested and compared. The probe used
previously in Chapter 5 is denoted as Probe #0. Probe #1 has a sequence of
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Figure 21 Responses of Zika virus RNA in lysing or GuSCN solution containing 1%
serum by various probes.
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TCTTCAGCCTCCATGTGTCATTCTTTTCACTTTCAA, and Probe #2 has a sequence
of TTTCGCTCTATCTTCGTCAGTTTCATATCCAATCAT. Probe #1 and #2 both have
a 100% match with Zika virus Uganda Strain, with target genomic sequence regions of
3116-3081 and 1427-1462 of Zika virus (strain MR 776, GenBank: AY632535.2)[77].
Although responses by sensors functionalized with Probes #1 and #2 show higher
sensitivity than those with Probe #0, Probe #2 demonstrates a much higher sensor readouts.
By comparing results of target RNA prepared in 1% serum/lysing and 1% serum/GuSCN,
it can be concluded that diluting Zika RNA into testing buffer containing GuSCN solution
(green) does not make any improvement over that into lysing solution (blue). This might
be due to the high conductivity that GuSCN has. At sensor’s working frequency of 100
kHz, the equivalent circuit of the sensor electrodes can be simplified as bulk solution
resistance Rs in serial with interfacial capacitance Cint. The bulk solution resistance is 3.28
kΩ and 84.1 Ω in 1:1 mixture of 1% serum/lysing solution and 1:1 mixture of 1%
serum/GuSCN solution respectively. The impedance of interfacial capacitance is
calculated to be 564.9 Ω in 1% serum/lysing solution and 39.9 Ω in 1% serum/GuSCN
solution. Consequently, 85.32% of the total applied AC signal (~8.53 mV) is applied over
the bulk 1% serum/lysing solution and 67.78% (~6.78 mV) over the bulk 1%
serum/GuSCN solution. Therefore, with buffer in lower conductivity, more electric field is
applied and utilized to induce DEP for bioparticle enrichment.
Next, sensor’s specificity is evaluated by using Dengue virus RNA as interference.
Probe # 1 and # 2 are used for sensor electrodes functionalization and both Zika virus RNA
(target) and Dengue virus RNA (interference) are spiked into 1:1 mixture of serum and
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lysing solution. Given 2×SSC solution’s aid in RNA target-probe hybridization, 2×SSC is
adopted to make 1:1:1 mixture of serum, GuSCN and 2×SSC to improve the performance
of testing buffer containing GuSCN solution used in previous assay (green curve in Figure
21). Therefore, Zika and Dengue virus RNA are also spiked into 1:1:1 mixture of serum,
GuSCN and 2×SSC to find out the optimal combination of probe and testing buffer which
would offer both excellent sensor sensitivity, readouts, as well as specificity. In figure 22(a)
and 23(b), for Probe #1, tests of Dengue virus RNA utilizing 1:1:1 mixture of serum,
GuSCN and 2×SSC as testing solution demonstrates both lower responses and curve slope,
meaning 1:1:1 mixture of serum, GuSCN and 2×SSC as testing solution shows superiority
in sensor’s specificity. The similar results are also observed in tests with Probe #2 (Figure
22(c) and 22(d)). In addition, by adding 2×SSC, sensor also yields higher response
compared with responses from previous GuSCN solution. Thus, if comparisons are made
between Figure 22(a)(c) and Figure 22(c)(d), it can be easily concluded that sensor yields
the optimal performances on sensitivity and specificity with electrodes functionalized with
Probe #2 and target Zika RNA (interference Dengue virus RNA) in 1:1:1 mixture of serum,
GuSCN and 2×SSC as testing solution.
In Figure 23, the percentage rate of serum in the optimized testing buffer is adjusted
from 33% to 50% (from 1:1:1 mixture to 2:1:1). In order to be able to evaluate the effect
this adjustment will have on the sensor’s performance, the Zika virus RNA concentration
is converted into the equivalent concentration in pure serum.For the adjusted testing buffer
of 2:1:1 mixture, sensor indicates a less sensitive dose response with 2.29±0.20 %/min for
0.3752×103 copies/μL, 5.23±0.46 %/min for 3.752×103 copies/μL and 9.08±1.07 %/min

56

Figure 22 Zika and Dengue virus RNA responses with various probes (Probe #1 and #2)
and testing buffer containing pure serum: (a) Probe #1 with 1:1:1 of serum, GuSCN and
2×SSC as testing buffer; (b) Probe #1 with 1:1 of serum and lysing solution as testing
buffer; (c) Probe #2 with 1:1:1 of serum, GuSCN and 2×SSC as testing buffer; and (d)
Probe #2 with 1:1 of serum and lysing solution as testing buffer.

Figure 23 Responses of tests on Probe #2 functionalized electrodes vs. Zika virus RNA
concentration converted into pure serum.
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for 37.52×103 copies/μL.While for 1:1:1 mixture, 0.5628×103 copies/μL, 5.628×103
copies/μL and 56.28×103 copies/μL Zika virus RNA in pure serum have responses of
2.62±0.64 %/min, 6.33±0.67 %/min and 10.92±0.66 %/min respectively.
6.3.3 HSV-1 DNA
In order to avoid the protein sediment in serum when samples are heated to 95 °C
for DNA denaturation, DNA serum spiked samples are diluted into lysing solution. Lysing
solution can break down peptide bonds, digest proteins in serum and help reduce sediment
that may affect DNA hybridization during tests. In Figure 24, 900 pg/mL HSV-1 DNA in
undiluted serum is 1:2, 1:2.5, 1:3.3, 1:5, 1:10 and 1:20 diluted into lysing solution
respectively before denaturation (actual concentration in serum is 450 pg/mL, 360 pg/mL,
270 pg/mL, 180 pg/mL, 90 pg/mL and 45 pg/mL). For dilution factor ranged from 1:2 to
1:20, sensors’ responses are 0.50±0.19 %/min, -1.38±0.55 %/min, -2.46±0.15 %/min, 3.437±0.28 %/min, -5.64±0.59 %/min and -6.34±0.49 %/min with a background response
of -0.38±0.20 %/min. It can be concluded that serum spiked samples with more dilution
will yield higher d|C|/dt responses. 1:20 and 1:10 in Figure 24 shows the highest yet
comparable responses. Therefore, dilution factors of 1:20 and 1:10 are used in the
subsequent experiments of HSV-1 DNA spiked serum samples.
Figure 25 demonstrates the logarithmic dependence of HSV-1 DNA concentrations
on sensor response (d|C|/dt in %/min). The shown HSV-1 DNA concentrations are
concentrations in neat serum, which are 90 pg/mL, 900 pg/mL and 9 ng/mL. Two dilution
factors of 1:20 and 1:10 show similar performances in Figure 25. The LOD are calculated
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Figure 24 Responses of DNA spiked serum diluted in lysing solution using different
dilution factors.

Figure 25 Dose response of HSV-1 DNA serum samples with 1:20 and 1:10 dilution.
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to be 19.46 pg/mL (125.98 copies/μL or 0.21 fM) and 29.73 pg/mL (192.46 copies/μL or
0.32 fM) for 1:20 and 1:10 dilution respectively. Since samples with 1:20 dilution show
slight advantages on sensitivity, LOD and sensor readouts, it is considered to be the optimal
dilution factor for HSV-1 DNA spiked serum sample tests.
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CHAPTER 7
EXPANSION TO CHEMICAL DETECTION
Reproduced in part with permission from Bisphenol A Sensors on Polyimide
Fabricated by Laser Direct Writing for Onsite River Water Monitoring at Attomolar
Concentration, Cheng Cheng, Shutong Wang, Jayne Wu, Yongchao Yu, Ruozhou Li,
Shigetoshi Eda, Jiangang Chen, Guoying Feng, Benjamin Lawrie, and Anming Hu, ACS
Applied Materials & Interfaces 2016 8 (28), 17784-17792, DOI: 10.1021/acsami.6b03743.
Copyright 2016 American Chemical Society.
In recent years, there is an increasing interest in developing effective tools for
bisphenol A (BPA) detection in the environment and food supply. Different from the
protein, virus or nucleic acids in size, BPA is small molecule and a different ac
electrokinetics mechanism, ac electroosmotic (ACEO) effect, is used for more effective
transport of the target analyte in water. In this work, ACEO-based capacitive sensing is
used to detect the binding of BPA with aptamer at the electrode surface. In additional, to
further reduce the sensor cost and improve the LOD for water monitoring, laser printed
electrodes on polyimide are adopted as the sensor in this work.

7.1 Electrodes fabrication
The laser written electrodes used in this work are fabricated by a femtosecond (fs)
pulsed laser (Cazadero, Calmar Laser Inc.) and a 532 nm CW laser (Verdi G5, Coherent)
via a 20 × microscope objective (NA=0.42) on the flexible Polyimide (PI) sheet
(Kapton_HN, 100 µm thickness) (Figure 26(a)). The fs laser generates pulses with 1030
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Figure 26 (a) Schematic illustration of the laser direct writing of electrode on a
polyimide substrate, (b) Typical photo image of flexible electrodes, (c) SEM images of
the porous carbonized structures and (d) Raman spectra of the polyimide regimes with
and without laser irradiation.
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nm central wavelength, and 400 fs pulse duration at a repetition rate of 120 kHz. The PI
films are mounted on an XY-translation stage controlled by a computer. In our case, the fs
laser and CW laser power concentrated on the sample surface are 230 mW and 85 mW
with a spot size of 3-5 μm, respectively, and a scanning speed of 0.5 mm/s. All irradiation
is performed in air environment under normal incidence. The gap distance between
adjacent finger electrodes is fixed at 90 μm, and a total of 8 pairs of electrode fingers are
written in one sensor (Figure 26(b)). The generation of black lines on the polyimide sheet
after the laser scanning confirmed the carbonization of the polymer. Figure 26(c) illustrates
the porous flake structures of the irradiated regimes. This porosity is a result of polyimide
molecules initially dissociating in the vicinity of focal point of the fs laser as a result of
multi-photon absorption[78]–[80]. Raman spectra shown in Figure 26(d) indicates the
recorded at three areas under excitation at 532 nm: (1) near the center of the carbonized
electrode, (2) about 40 µm away from the center, and (3) at the unexposed PI film.
Prior to irradiation, the PI film is cleaned using ethanol. Finally, the surface
morphology is observed using optical microscopy and scanning electronic microscopy
(Zeiss Auriga). After surface treatment by plasma cleaner or ozone cleaner, a
microchamber is attached to the foil surface for surface functionalization and subsequent
sensing.
Appropriate working frequency is also vital in this work and can be found and
estimated by the equivalent circuit cell fitting. For example, an optimal frequency at which
ACEO flow velocity peaks for a given AC voltage needs to be selected in the BPA
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detection. Referring to Equation 3.2, 𝐸𝑡 is dependent on the bulk impedance (Rs and Cs)
and 𝛥𝜉 is dependent on the interfacial impedance (Rct and Cint).
By fitting the measured impedance spectrum with the equivalent circuit model of
laser writing electrodes shown in Figure 2, the values for each circuit element in Figure 2
are found as follows, Rwire = 450 Ω, Cint = 0.7 µF, Rct = 30 kΩ, Rs = 500 Ω and Cs = 6.1 pF.
The fitting curves along with the measured impedance data are shown in Figure 27. At low
frequency (below 100 kHz), the electrical current between an electrode pair predominately
takes the path formed by Cint and Rs.

7.2 Reagents and samples
20 M BPA aptamer in ultrapure water is used for incubation. Analytical BPA
samples are prepared as 0.1 fM, 1.0 fM, 10 fM, 100 fM and 1 pM BPA in ultrapure water.
Surface water samples are collected from Tennessee River near a waste water treatment
plant in Knoxville and are diluted at 1:1,000,000 in ultrapure water prior to testing. No
filtering is performed.

7.3 Capacitance change with time during assay
Ultrapure (Mili-Q) water as the background solution is also tested as the control.
Each measurement is performed with an AC signal of 300 mV, 1 kHz for 20 seconds. As
shown in Figure 28, the negative samples of 10 pM BPS (0.14 %/min) and BPF
(0.35 %/min), and the control sample (-0.66 %/min) exhibited virtually no measurable shift
in capacitance, while the positive samples containing trace BPA in water, gave a
capacitance change of -19.39 %/min, -21.40 %/min, -29.65 %/min, -38.20 %/min and 44.10 %/min at 1 fM, 10 fM, 100 fM and 1 pM respectively.
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Figure 27 The measured impedance spectra (solid line) of the electrode cell and its
equivalent circuit fitting (dotted line).

Figure 28 Normalized capacitance changes of control, BPA, BPS and BPF samples with
time.
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7.4 Working condition optimization
Based on Equation 3.2, ACEO flow velocity is strongly dependent on the voltage
and frequency. Therefore, AC voltage level and frequency need to be optimized to fully
take advantage of ACEO effect. Figure 29 shows the results when optimizing AC voltage
level and frequency. All the tests are performed with 1fM BPA in ultrapure (Mili-Q) water.
First the sensor responses are measured with AC voltage level varied from 100 mV to 400
mV at the frequency of 1 kHz. Figure 29(a) demonstrates that, the capacitive response
decreased monotonically as the voltage increased from 100 mV to 400 mV, showing that
higher AC voltage contributed to larger sensor response. When the voltage level is above
300 mV, the increase in sensor response became limited, due to saturation of binding sites
on the sensor. Therefore, the optimal voltage level is determined to be 300 mV. The control
samples of ultrapure water exhibited a noise limited response ranged from -0.52 to
1.26 %/min.
Figure 29(b) illustrates the frequency dependence of the sensor under a 300 mV AC
signal whose frequency varied from 500 Hz to 10 kHz, with a well-defined maximum
response at 1 kHz. This is in agreement with the bell-shaped frequency dependence of
ACEO velocity, validating that ACEO effect is indeed the responsible mechanism for rapid
and sensitive detection. Therefore, AC signal of 300 mV at 1 kHz is used in all the
subsequent experiments.

7.5 Dose response
0.1 fM to 1 pM BPA samples are tested on the sensor to obtain the sensor’s BPA
dose response with an assay time of 20 seconds, and the results are shown in Figure 30 (a).
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Figure 29 Response of control and 1 fM BPA samples (a) when using 1 kHz AC signal
with its voltage varied from 100 mV to 400 mV and (b) when using 300 mV AC signal
with its frequency varied from 500 Hz to 10 kHz.

Figure 30 Detected dose response of BPA samples as a function of concentration by data
obtained in (a) 20 seconds and (b) 10 seconds.
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Each BPA concentration is tested in triplicate using a new sensor each time. The responses
from the water samples again are shown to be negligible, -0.47±0.94 %/min. The response
from DMSO which is used as solvent in initial stock solution preparations for all the test
compounds is also tested. The final concentration of DMSO in working solutions of all test
compounds is 1.0 ppm with a negligible response of dC/dt of -1.22±1.19 %/min. The
magnitude of dC/dt, or |dC/dt|, increases monotonically with increasing BPA concentration
from 0.1fM to 1pM, with -6.48±1.08 %/min for 100 aM BPA and -41.9±2.47 %/min for
1pM BPA. The increase in |dC/dt| with BPA level is slower than logarithm dependence,
again due to rapid saturation of binding sites at higher BPA concentrations. Therefore, the
dependence of dC/dt on BPA concentration is approximated by both quadratic curve and
linear fittings as follow:
𝑦 = 1.468lg 2 𝑥 − 11.591lg𝑥 − 19.836

(7.1)

𝑦 = −9.392lg𝑥 − 17.885

(7.2)

where x is the BPA concentration in fM and y is the capacitance change per minute, dC/dt.
The correlation coefficient R2 is 0.989 and 0.943 for the quadratic curve and linear fitting
respectively. Figure 30(b) demonstrates the sensor’s dose response based on the first 10
seconds’ data points of the acquired sensor readout values. By analyzing the data of the
first 10 seconds, binding sites’ saturation effects can be diminished, allowing the sensor to
each a much lower LOD of 16.10 aM. Since the quadratic fitting gives a more precise
description of the characteristic of the dose response, it is adopted in the subsequent
analysis.
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The limit of detection is found based on the fitting curve, which is defined as 3
standard deviations (1.19 %/min) from the response of background control: DMSO (1.22±1.19 %/min). The cut-off dC/dt is found to be -4.78 %/min, which corresponds to a
BPA concentration of 58.28 aM.

7.6 Specificity
BPA’s analogues BPS and BPF (bisphenol S and bisphenol F), and two of BPA
metabolites, β-D-glucuronide and monosulfate salt, are used as interference or non-specific
molecules to determine the specificity of the functionalized aptamer sensor. Their
responses are shown in Figure 31. Tests are conducted with an AC signal of 300 mV and
1 kHz applied to the sensor. BPA-G and BPA-M in Figure 31 represent BPA β-Dglucuronide and monosulfate salt respectively. BPS and BPF samples are tested at 1 pM
and 10 pM, and β-D-glucuronide and monosulfate salt are 100 fM and 10 pM. In Figure
31, the control samples of ultrapure water (0.44±0.64 %/min) and dimethlsulfoxide,
DMSO, (-1.22±1.19 %/min), and 1 fM and 10 fM BPA results are listed as well for
comparison. BPS (4.22±0.66 %/min for 1 pM and 3.29±0.09 %/min for 10 pM), BPF
(5.41±1.13 %/min for 1pM and 4.25±0.26 %/min for 10 pM), and monosulfate salt
(7.91±5.44 %/min for 100 fM and 0.22±1.15 %/min for 10 pM) all yielded small negative
responses. However, glucuronide salt (-11.90±2.36 %/min for 100 fM and -22.33±3.20
%/min for 10 pM) yielded a positive response but only at much high level of
concentrations. The 100 fM glucuronide salt’s response is calculated to be equivalent to
BPA’s response at 0.23 fM, demonstrating that the sensor’s selectivity against glucuronide
is 430:1. It is known the glucuronidation and sulfation of environmental phenols are the
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Figure 31 Illustration of sensor specificity. The blue line is the sensor response of LOD
(58.28 aM)
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major BPA metabolic pathways identified in human and animals.[81] Our results indicate
that proper dilutions would be necessary when the same aptamer is used for free BPA
detection from biological matrices.

7.7 Complex river samples
In order to test the performance of the sensor in complex matrix, and to illustrate
the selectivity against various non-specific compounds, two river water samples are
collected near a local waste treatment plant and diluted 1:1,000,000 in ultrapure water prior
to testing. The diluted river water samples are then spiked with 5 fM BPA and performed
recovery tests. The percentage recovery (% Recovery) is calculated as:
% Recovery =

𝑐𝑠𝑝𝑖𝑘𝑒𝑑 𝑟𝑖𝑣𝑒𝑟 𝑠𝑎𝑚𝑝𝑙𝑒 −𝑐𝑢𝑛𝑠𝑝𝑖𝑘𝑒𝑑 𝑟𝑖𝑣𝑒𝑟 𝑠𝑎𝑚𝑝𝑙𝑒
5 𝑓𝑀

×100%

(7.3)

BPA concentration in the river water samples are found by using Equation 6.1, i.e.
solving for x using the measured dC/dt as y. Table 3 shows the sensor response for river
water samples with the corresponding concentration interpreted using Equation 6.1.
Diluted surface water sampled from up and down streams yielded a measured
concentration of 0.53 fM and 0.30 fM BPA, which corresponds to original BPA
concentrations of 0.53 nM and 0.30 nM respectively. Those values are in agreement with
BPA levels reported in the literature.[82],[83]. The subsequent recovery experiments
obtained recovery rates of 83.61% and 100.70% for 5 fM BPA added to river water.
Based on our study, the sensing mechanism can be summarized in Figure 32.
Enhanced by ACEO effect, BPA particles are carried to the electrode’s surface by fluid
flows during capacitance measurement, together with interference particles such as BPS.
Since the aptamer deposited on the electrode’s surface can only bind with BPA specifically,
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Table 3 Surface water samples detection and recoveries.
Sample

dC/dt
[%/min]

Interpreted Concentration
[fM]

Downstream

-16.48±0.63

0.53

Mixed with 5 fM sample

-26.97±1.59

4.71

Upstream

-13.49±1.25

0.31

Mixed with 5 fM sample

-27.49±1.83

5.34

Recovery
[%]

83.61

100.70

Figure 32 Ultrasensitive capacitive sensors with directed movement of complex sample
particles with applied the ACEO effect.
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trace concentrations of BPA increase the layer thickness and decrease the interfacial
capacitance. The nanostructured surface increases the area to immobilize aptamer,
significantly increasing the sensitivity.
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CHAPTER 8
CONCLUSONS AND FUTURE WORK
8.1 Conclusions
This work demonstrates a low cost bio sensing platform that can be used for
pathogens and infections diagnosis. By inducing ACEK for particles manipulation and
acceleration, the sensing platform realizes sample enrichment and binding reaction
measurement simultaneously, which leads to the sensor to be rapid, sensitive and specific.
The achievements of this work include:
(1) Different electrodes are investigated to study their suitability for direct
capacitive sensing method in order to support rapid and low cost biosensing.
Well-designed electrodes should have lower internal resistance and an
interfacial-bulk capacitance ratio that is great than at least 103.
(2) Much higher sensitivity in detection has been achieved using cross linkers, as
well as by optimizing testing and incubation buffers. The improvement in
sensor response from adopting linkers is significant in detecting influenza A
virus and protein IgG . Tests of influenza A virus and protein IgG obtain LODs
of 15 pg/mL and 4.513 fg/mL respectively in 30 seconds. However, without
linker modification on sensor electrodes, the sensor shows quite small
responses with an LOD of 1 ng/mL in protein IgG detection and is not even
able to differentiate various concentrations of influenza A virus analytical
samples. In addition to linkers, various incubation and testing buffers are also
critical to bioparticles detection. After optimization of incubation and testing
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buffers in nuclei acid detection, specific detection of human herpesvirus-1
(HSV-1) dsDNA can be achieved within 30 seconds with an LOD of 1 pg/mL
(6.5 copies/μL or 10.7 aM) in standard buffer, and 20 pg/mL (129.5 copies/μL
or 0.21 fM) in neat serum.
(3) This bio-sensing platform can be expanded to chemical detection. Chemicals
are very small molecules compared with virus or proteins, and DEP is not able
to contribute in this application. AC electroosmotic effect, however, can be
utilized for enrichment of small molecules, expanding the varieties of ACEK
capacitive sensing, as well as the application in chemical detection. Detection
of bisphenol A (BPA) by electrodes on flexible polyimide substrate possesses
selectivity and an LOD of 58.28 aM corresponding to a rapid integration time
of only 20 seconds. As for the complex samples, the sensor reaches 83.61% and
100.70% recovery of two surface water samples.
To summarize, this work demonstrates a successful development of innovative
sensors for virus, protein, nuclei acid and small chemical molecules detection at
ultra low concentration. This research provides a framework of low cost and
practical sensing for on-site disease diagnosis and environmental monitoring.

8.2 Future work
Firstly, this developed bio-sensing platform is very promising for detecting target
particles in complex matrix. Currently, the sensor is demonstrated to work with diluted
serum samples. In the future, we will try to integrate the sensor with a wicking material,
such as a piece of filter paper, on top of the sensing area for sample load. By doing so, it is
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anticipated that the wicking material will retain the blood cells and allow smaller particles
such as proteins to move towards the sensor by capillary force, thus making it possible for
the sensor to work with whole blood directly.
Secondly, with integration of a board-level capacitance measuring and readout
system, this platform can be realized into a portable device with multiple channels used for
on-site sensing, monitoring and screening tests.

76

LIST OF REFERENCES

77
[1] L. C. Clark, “Monitor and control of blood and tissue oxygenation,” Trans Am. Soc.
Artif. Intern. Organs, vol. 2, pp. 41–48, 1956.
[2] W. R. Heineman and W. B. Jensen, “Leland C. Clark Jr. (1918–2005),” Biosens.
Bioelectron., vol. 21, no. 8, pp. 1403–1404, Feb. 2006.
[3] A. P. F. Turner, “Biosensors: sense and sensibility,” Chem. Soc. Rev., vol. 42, no. 8,
p. 3184, 2013.
[4] V. Sikka et al., “The emergence of zika virus as a global health security threat: A
review and a consensus statement of the INDUSEM Joint working Group (JWG),” J.
Glob. Infect. Dis., vol. 8, no. 1, p. 3, 2016.
[5] I. I. Bogoch et al., “Anticipating the international spread of Zika virus from Brazil,”
The Lancet, vol. 387, no. 10016, pp. 335–336, Jan. 2016.
[6] M. R. Duffy et al., “Zika Virus Outbreak on Yap Island, Federated States of
Micronesia,” N. Engl. J. Med., vol. 360, no. 24, pp. 2536–2543, Jun. 2009.
[7] WHO, “Zika virus and complications: Questions and answers,” 28-Jul-2016.
[Online]. Available: http://www.who.int/features/qa/zika/en/.
[8] S. JAMES, “Global Bisphenol A (BPA) Market By Application (Appliances,
Automotive, Consumer, Construction, Electrical & Electronics) Expected To Reach
USD 20.03 Billion by 2020,” Jun-2014.
[9] E. R. Hugo, T. D. Brandebourg, J. G. Woo, J. Loftus, J. W. Alexander, and N. BenJonathan, “Bisphenol A at Environmentally Relevant Doses Inhibits Adiponectin
Release from Human Adipose Tissue Explants and Adipocytes,” Environ. Health
Perspect., vol. 116, no. 12, pp. 1642–1647, Aug. 2008.
[10] R. R. Newbold, W. N. Jefferson, and E. Padilla-Banks, “Prenatal Exposure to
Bisphenol A at Environmentally Relevant Doses Adversely Affects the Murine
Female Reproductive Tract Later in Life,” Environ. Health Perspect., vol. 117, no. 6,
pp. 879–885, Jun. 2009.
[11] H. Cui, J. Wu, S. Eda, J. Chen, W. Chen, and L. Zheng, “Rapid capacitive detection
of femtomolar levels of bisphenol A using an aptamer-modified disposable
microelectrode array,” Microchim. Acta, vol. 182, no. 13–14, pp. 2361–2367, Oct.
2015.
[12] R. Fogel and J. Limson, “Developing Biosensors in Developing Countries: South
Africa as a Case Study,” Biosensors, vol. 6, no. 1, p. 5, Feb. 2016.
[13] A. P. F. Turner, I. Karube, and G. S. Wilson, Eds., Biosensors: fundamentals and
applications. Oxford [Oxfordshire] ; New York: Oxford University Press, 1987.
[14] N. J. Ronkainen, H. B. Halsall, and W. R. Heineman, “Electrochemical biosensors,”
Chem. Soc. Rev., vol. 39, no. 5, p. 1747, 2010.
[15] Y. Wan, Y. Su, X. Zhu, G. Liu, and C. Fan, “Development of electrochemical
immunosensors towards point of care diagnostics,” Biosens. Bioelectron., vol. 47, pp.
1–11, Sep. 2013.
[16] D. R. Thévenot, K. Toth, R. A. Durst, and G. S. Wilson, “Electrochemical biosensors:
recommended definitions and classification1International Union of Pure and Applied
Chemistry: Physical Chemistry Division, Commission I.7 (Biophysical Chemistry);
Analytical Chemistry Division, Commission V.5 (Electroanalytical Chemistry).1,”
Biosens. Bioelectron., vol. 16, no. 1–2, pp. 121–131, Jan. 2001.

78
[17] M. ’delanji Vestergaard, K. Kerman, and E. Tamiya, “An Overview of Label-free
Electrochemical Protein Sensors,” Sensors, vol. 7, no. 12, pp. 3442–3458, Dec. 2007.
[18] Y. Wang, H. Xu, J. Zhang, and G. Li, “Electrochemical Sensors for Clinic Analysis,”
Sensors, vol. 8, no. 4, pp. 2043–2081, Mar. 2008.
[19] M. Morikawa, N. Kimizuka, M. Yoshihara, and T. Endo, “New Colorimetric
Detection of Glucose by Means of Electron-Accepting Indicators: Ligand
Substitution of [Fe(acac)3−n(phen)n]n+ Complexes Triggered by Electron Transfer
from Glucose Oxidase,” Chem. - Eur. J., vol. 8, no. 24, pp. 5580–5584, Dec. 2002.
[20] Y. Miwa, M. Nishizawa, T. Matsue, and I. Uchida, “A Conductometric Glucose
Sensor Based on a Twin-Microband Electrode Coated with a Polyaniline Thin Film.,”
Bull. Chem. Soc. Jpn., vol. 67, no. 10, pp. 2864–2866, 1994.
[21] S. Mansouri and J. S. Schultz, “A Miniature Optical Glucose Sensor Based on
Affinity Binding,” Bio/Technology, vol. 2, no. 10, pp. 885–890, Oct. 1984.
[22] J. C. Pickup, F. Hussain, N. D. Evans, O. J. Rolinski, and D. J. S. Birch,
“Fluorescence-based glucose sensors,” Biosens. Bioelectron., vol. 20, no. 12, pp.
2555–2565, Jun. 2005.
[23] E.-H. Yoo and S.-Y. Lee, “Glucose Biosensors: An Overview of Use in Clinical
Practice,” Sensors, vol. 10, no. 5, pp. 4558–4576, May 2010.
[24] C. A. Rowe-Taitt, J. W. Hazzard, K. E. Hoffman, J. J. Cras, J. P. Golden, and F. S.
Ligler, “Simultaneous detection of six biohazardous agents using a planar waveguide
array biosensor,” Biosens. Bioelectron., vol. 15, no. 11–12, pp. 579–589, Dec. 2000.
[25] X. Liu, K. Yang, A. Wadhwa, S. Eda, S. Li, and J. Wu, “Development of an AC
electrokinetics-based immunoassay system for on-site serodiagnosis of infectious
diseases,” Sens. Actuators Phys., vol. 171, no. 2, pp. 406–413, Nov. 2011.
[26] S. Haeberle and R. Zengerle, “Microfluidic platforms for lab-on-a-chip applications,”
Lab. Chip, vol. 7, no. 9, p. 1094, 2007.
[27] R. M. Lequin, “Enzyme Immunoassay (EIA)/Enzyme-Linked Immunosorbent Assay
(ELISA),” Clin. Chem., vol. 51, no. 12, pp. 2415–2418, Dec. 2005.
[28] X. Yang, J. Janatova, J. M. Juenke, G. A. McMillin, and J. D. Andrade, “An
ImmunoChip prototype for simultaneous detection of antiepileptic drugs using an
enhanced one-step homogeneous immunoassay,” Anal. Biochem., vol. 365, no. 2, pp.
222–229, Jun. 2007.
[29] G. Blagoi, S. Keller, A. Johansson, A. Boisen, and M. Dufva, “Functionalization of
SU-8 photoresist surfaces with IgG proteins,” Appl. Surf. Sci., vol. 255, no. 5, pp.
2896–2902, Dec. 2008.
[30] Y. Gao, F. Y. H. Lin, G. Hu, P. M. Sherman, and D. Li, “Development of a novel
electrokinetically driven microfluidic immunoassay for the detection of Helicobacter
pylori,” Anal. Chim. Acta, vol. 543, no. 1–2, pp. 109–116, Jul. 2005.
[31] D. Hoegger, P. Morier, C. Vollet, D. Heini, F. Reymond, and J. S. Rossier,
“Disposable microfluidic ELISA for the rapid determination of folic acid content in
food products,” Anal. Bioanal. Chem., vol. 387, no. 1, pp. 267–275, Dec. 2006.
[32] F. Y. H. Lin, M. Sabri, D. Erickson, J. Alirezaie, D. Li, and P. M. Sherman,
“Development of a novel microfluidic immunoassay for the detection of Helicobacter
pylori infection,” The Analyst, vol. 129, no. 9, p. 823, 2004.

79
[33] L. Yu, Y. Liu, Y. Gan, and C. M. Li, “High-performance UV-curable epoxy resinbased microarray and microfluidic immunoassay devices,” Biosens. Bioelectron., vol.
24, no. 10, pp. 2997–3002, Jun. 2009.
[34] X. Zhao and S. A. Shippy, “Competitive Immunoassay for Microliter Protein Samples
with Magnetic Beads and Near-Infrared Fluorescence Detection,” Anal. Chem., vol.
76, no. 7, pp. 1871–1876, Apr. 2004.
[35] K. Sato et al., “Integration of an Immunosorbent Assay System: Analysis of Secretory
Human Immunoglobulin A on Polystyrene Beads in a Microchip,” Anal. Chem., vol.
72, no. 6, pp. 1144–1147, Mar. 2000.
[36] A. W. Martinez, S. T. Phillips, M. J. Butte, and G. M. Whitesides, “Patterned Paper
as a Platform for Inexpensive, Low-Volume, Portable Bioassays,” Angew. Chem. Int.
Ed., vol. 46, no. 8, pp. 1318–1320, Feb. 2007.
[37] E. Fu, B. Lutz, P. Kauffman, and P. Yager, “Controlled reagent transport in disposable
2D paper networks,” Lab. Chip, vol. 10, no. 7, p. 918, 2010.
[38] A. W. Martinez, S. T. Phillips, G. M. Whitesides, and E. Carrilho, “Diagnostics for
the Developing World: Microfluidic Paper-Based Analytical Devices,” Anal. Chem.,
vol. 82, no. 1, pp. 3–10, Jan. 2010.
[39] B. B. Haab, “Methods and applications of antibody microarrays in cancer research,”
PROTEOMICS, vol. 3, no. 11, pp. 2116–2122, Nov. 2003.
[40] H. Jiang, X. Weng, and D. Li, “Microfluidic whole-blood immunoassays,”
Microfluid. Nanofluidics, vol. 10, no. 5, pp. 941–964, May 2011.
[41] J. Homola, S. S. Yee, and G. Gauglitz, “Surface plasmon resonance sensors: review,”
Sens. Actuators B Chem., vol. 54, no. 1–2, pp. 3–15, Jan. 1999.
[42] H. Tanaka, M. Hanasaki, T. Isojima, H. Takeuchi, T. Shiroya, and H. Kawaguchi,
“Enhancement of sensitivity of SPR protein microarray using a novel 3D protein
immobilization,” Colloids Surf. B Biointerfaces, vol. 70, no. 2, pp. 259–265, May
2009.
[43] M. H. F. Meyer, M. Hartmann, and M. Keusgen, “SPR-based immunosensor for the
CRP detection—A new method to detect a well known protein,” Biosens.
Bioelectron., vol. 21, no. 10, pp. 1987–1990, Apr. 2006.
[44] T. Endo, K. Kerman, N. Nagatani, Y. Takamura, and E. Tamiya, “Label-Free
Detection of Peptide Nucleic Acid−DNA Hybridization Using Localized Surface
Plasmon Resonance Based Optical Biosensor,” Anal. Chem., vol. 77, no. 21, pp.
6976–6984, Nov. 2005.
[45] S. Sabban, “Development of an in vitro model system for studying the interaction of
Equus caballus IgE with its high- affinity FcεRI receptor,” PhD Thesis, The
University of Sheffield, 2011.
[46] F.-C. Chien and S.-J. Chen, “A sensitivity comparison of optical biosensors based on
four different surface plasmon resonance modes,” Biosens. Bioelectron., vol. 20, no.
3, pp. 633–642, Oct. 2004.
[47] B. Liedberg, C. Nylander, and I. Lunström, “Surface plasmon resonance for gas
detection and biosensing,” Sens. Actuators, vol. 4, pp. 299–304, Jan. 1983.

80
[48] R. P. H. Kooyman, H. Kolkman, J. Van Gent, and J. Greve, “Surface plasmon
resonance immunosensors: sensitivity considerations,” Anal. Chim. Acta, vol. 213,
pp. 35–45, 1988.
[49] V. Owen, “Real-time optical immunosensors — A commercial reality,” Biosens.
Bioelectron., vol. 12, no. 1, pp. i–ii, Jan. 1997.
[50] K. A. Peterlinz, R. M. Georgiadis, T. M. Herne, and M. J. Tarlov, “Observation of
Hybridization and Dehybridization of Thiol-Tethered DNA Using Two-Color
Surface Plasmon Resonance Spectroscopy,” J. Am. Chem. Soc., vol. 119, no. 14, pp.
3401–3402, Apr. 1997.
[51] L. S. Jung, C. T. Campbell, T. M. Chinowsky, M. N. Mar, and S. S. Yee, “Quantitative
Interpretation of the Response of Surface Plasmon Resonance Sensors to Adsorbed
Films,” Langmuir, vol. 14, no. 19, pp. 5636–5648, Sep. 1998.
[52] J. Homola, S. S. Yee, and G. Gauglitz, “Surface plasmon resonance sensors: review,”
Sens. Actuators B Chem., vol. 54, no. 1–2, pp. 3–15, Jan. 1999.
[53] M. C. Rodriguez, A.-N. Kawde, and J. Wang, “Aptamer biosensor for label-free
impedance spectroscopy detection of proteins based on recognition-induced
switching of the surface charge,” Chem. Commun., no. 34, p. 4267, 2005.
[54] E. Katz and I. Willner, “Probing Biomolecular Interactions at Conductive and
Semiconductive Surfaces by Impedance Spectroscopy: Routes to Impedimetric
Immunosensors, DNA-Sensors, and Enzyme Biosensors,” Electroanalysis, vol. 15,
no. 11, pp. 913–947, Jul. 2003.
[55] J.-G. Guan, Y.-Q. Miao, and Q.-J. Zhang, “Impedimetric biosensors,” J. Biosci.
Bioeng., vol. 97, no. 4, pp. 219–226, Jan. 2004.
[56] I. O. K’Owino and O. A. Sadik, “Impedance Spectroscopy: A Powerful Tool for
Rapid Biomolecular Screening and Cell Culture Monitoring,” Electroanalysis, vol.
17, no. 23, pp. 2101–2113, Dec. 2005.
[57] M. I. Prodromidis, “Impedimetric immunosensors—A review,” Electrochimica Acta,
vol. 55, no. 14, pp. 4227–4233, May 2010.
[58] P. Bataillard, F. Gardies, N. Jaffrezic-Renault, C. Martelet, B. Colin, and B.
Mandrand, “Direct detection of immunospecies by capacitance measurements,” Anal.
Chem., vol. 60, no. 21, pp. 2374–2379, Nov. 1988.
[59] J. Wu, “Interactions of electrical fields with fluids:laboratory-on-a-chip applications,”
IET Nanobiotechnol., vol. 2, no. 1, pp. 14–27, 2008.
[60] K. Yang and J. Wu, “Numerical study of in situ preconcentration for rapid and
sensitive nanoparticle detection,” Biomicrofluidics, vol. 4, no. 3, p. 034106, 2010.
[61] J. Wu, Y. Ben, and H.-C. Chang, “Particle detection by electrical impedance
spectroscopy with asymmetric-polarization AC electroosmotic trapping,” Microfluid.
Nanofluidics, vol. 1, no. 2, pp. 161–167, May 2005.
[62] J. Wu, “Advances of LOC-Based Particle Manipulation by AC Electrical Fields,”
Recent Pat. Electr. Eng., vol. 1, no. 3, pp. 178–187, Nov. 2008.
[63] A. Castellanos, A. Ramos, A. González, N. G. Green, and H. Morgan,
“Electrohydrodynamics and dielectrophoresis in microsystems: scaling laws,” J.
Phys. Appl. Phys., vol. 36, pp. 2584–2597, 2003.

81
[64] N. G. Green, A. Ramos, A. González, H. Morgan, and A. Castellanos, “Fluid flow
induced by nonuniform ac electric fields in electrolytes on microelectrodes. I.
Experimental measurements,” Phys. Rev. E, vol. 61, no. 4, pp. 4011–4018, Apr. 2000.
[65] N. Islam, M. Lian, and J. Wu, “Enhancing microcantilever capability with integrated
AC electroosmotic trapping,” Microfluid. Nanofluidics, vol. 3, no. 3, pp. 369–375,
Apr. 2007.
[66] J. Wu and N. Islam, “A Simple Method to Integrate In Situ Nano-Particle Focusing
With Cantilever Detection,” IEEE Sens. J., vol. 7, no. 6, pp. 957–958, Jun. 2007.
[67] J. Wu, Y. Ben, D. Battigelli, and H.-C. Chang, “Long-Range AC Electroosmotic
Trapping and Detection of Bioparticles,” Ind. Eng. Chem. Res., vol. 44, no. 8, pp.
2815–2822, Apr. 2005.
[68] A. Ramos, H. Morgan, N. Green, and A. Castellanos, “AC electrokinetics: a review
of forces in microelectrode structures,” J. Phys. Appl. Phys., vol. 31, no. 18, pp. 2338–
2353, 1998.
[69] S. Li et al., “AC electrokinetics-enhanced capacitive immunosensor for point-of-care
serodiagnosis of infectious diseases,” Biosens. Bioelectron., vol. 51, pp. 437–443,
Jan. 2014.
[70] B. T. Least and D. A. Willis, “Modification of polyimide wetting properties by laser
ablated conical microstructures,” Appl. Surf. Sci., vol. 273, pp. 1–11, May 2013.
[71] H. Cui, C. Cheng, J. Wu, and S. Eda, “Rapid detection of progesterone by
commercially available microelectrode chips,” 2013, pp. 1–4.
[72] S. Li et al., “Alternating current electrokinetics enhanced in situ capacitive
immunoassay: Microfluidics and Miniaturization,” ELECTROPHORESIS, vol. 36,
no. 3, pp. 471–474, Feb. 2015.
[73] H. Cui et al., “An AC electrokinetic impedance immunosensor for rapid detection of
tuberculosis,” The Analyst, vol. 138, no. 23, pp. 7188–7196, 2013.
[74] W. Zhongliang et al., “Detection of the four major human herpesviruses
simultaneously in whole blood and cerebrospinal fluid samples by the fluorescence
polarization assay,” Int. J. Infect. Dis., vol. 14, no. 10, pp. e893–e897, Oct. 2010.
[75] C. Cheng et al., “An unamplified RNA sensor for on-site screening of Zika virus
disease in a limited resource setting,” ChemElectroChem, Jan. 2017.
[76] “M4RT,”
Thermo
Fisher
Scientific.
[Online].
Available:
http://www.remel.com/Catalog/Item.aspx?name=M4RT%-3csup%-3e%-26reg%3b%-3c%-2fsup%-3e.
[77] K. Pardee et al., “Rapid, Low-Cost Detection of Zika Virus Using Programmable
Biomolecular Components,” Cell, vol. 165, no. 5, pp. 1255–1266, May 2016.
[78] R.-Z. Li et al., “High-rate in-plane micro-supercapacitors scribed onto photo paper
using in situ femtolaser-reduced graphene oxide/Au nanoparticle microelectrodes,”
Energy Env. Sci, vol. 9, pp. 1458–1467, 2016.
[79] C. Zheng et al., “Femtosecond Laser Fabrication of Cavity Microball Lens (CMBL)
inside a PMMA Substrate for Super-Wide Angle Imaging,” Small, vol. 11, no. 25, pp.
3007–3016, Jul. 2015.

82
[80] R. Rahimi, M. Ochoa, W. Yu, and B. Ziaie, “Highly Stretchable and Sensitive
Unidirectional Strain Sensor via Laser Carbonization,” ACS Appl. Mater. Interfaces,
vol. 7, no. 8, pp. 4463–4470, Mar. 2015.
[81] N. Shangari, T. S. Chan, and P. J. O’Brien, “Sulfation and Glucuronidation of
Phenols: Implications in Coenyzme Q Metabolism,” in Methods in Enzymology, vol.
400, Elsevier, 2005, pp. 342–359.
[82] V. A. Santhi, N. Sakai, E. D. Ahmad, and A. M. Mustafa, “Occurrence of bisphenol
A in surface water, drinking water and plasma from Malaysia with exposure
assessment from consumption of drinking water,” Sci. Total Environ., vol. 427–428,
pp. 332–338, Jun. 2012.
[83] G. M. Klečka, C. A. Staples, K. E. Clark, N. van der Hoeven, D. E. Thomas, and S.
G. Hentges, “Exposure Analysis of Bisphenol A in Surface Water Systems in North
America and Europe,” Environ. Sci. Technol., vol. 43, no. 16, pp. 6145–6150, Aug.
2009.

83

VITA
Cheng Cheng joined The University of Tennessee at Knoxville in August 2012 to
pursue the Ph.D. degree in Electrical Engineering. He received his Master of Science from
Morehead State University in May 2012 and his Bachelor of Engineering from Guangxi
University, China in 2010. His research focus includes biomedical sensing instrumentation
and device application.

